| Year |
Citation |
Score |
| 2024 |
Wang Z, Lewis V, Stehmann C, Varghese S, Senesi M, McGlade A, Ellett LJ, Doecke JD, Eratne D, Velakoulis D, Masters CL, Collins SJ, Li QX. Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt-Jakob disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 16: e12548. PMID 38352040 DOI: 10.1002/dad2.12548 |
0.386 |
|
| 2024 |
Odenkirk MT, Zheng X, Kyle JE, Stratton KG, Nicora CD, Bloodsworth KJ, Mclean CA, Masters CL, Monroe ME, Doecke JD, Smith RD, Burnum-Johnson KE, Roberts BR, Baker ES. Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain Regions. Journal of Proteome Research. PMID 38236019 DOI: 10.1021/acs.jproteome.3c00604 |
0.639 |
|
| 2023 |
Lian Y, Jia YJ, Wong J, Zhou XF, Song W, Guo J, Masters CL, Wang YJ. Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer's disease. Molecular Psychiatry. PMID 38001337 DOI: 10.1038/s41380-023-02324-4 |
0.381 |
|
| 2023 |
Slee MG, Rainey-Smith SR, Villemagne VL, Doecke JD, Sohrabi HR, Taddei K, Ames D, Dore V, Maruff P, Laws SM, Masters CL, Rowe CC, Martins RN, Erickson KI, Brown BM. Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37984813 DOI: 10.1002/alz.13556 |
0.423 |
|
| 2023 |
Llibre-Guerra JJ, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, Strom A, Gordon B, Mundada N, Schindler SE, Tsoy E, Ma Y, Lu R, Fagan AM, Benzinger TLS, ... ... Masters CL, et al. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280. PMID 37942088 DOI: 10.1093/braincomms/fcad280 |
0.355 |
|
| 2023 |
Naismith SL, Michaelian JC, Santos C, Mehrani I, Robertson J, Wallis K, Lin X, Ward SA, Martins R, Masters CL, Breakspear M, Ahern S, Fripp J, Schofield PR, Sachdev PS, et al. Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and Plans. Journal of Alzheimer's Disease : Jad. PMID 37927266 DOI: 10.3233/JAD-230854 |
0.38 |
|
| 2023 |
Xia Y, Maruff P, Doré V, Bourgeat P, Laws SM, Fowler C, Rainey-Smith SR, Martins RN, Villemagne VL, Rowe CC, Masters CL, Coulson EJ, Fripp J. Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease. Neurobiology of Aging. 132: 120-130. PMID 37801885 DOI: 10.1016/j.neurobiolaging.2023.09.002 |
0.735 |
|
| 2023 |
Tosun D, Yardibi O, Benzinger TLS, Kukull WA, Masters CL, Perrin RJ, Weiner MW, Simen A, Schwarz AJ. Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37667412 DOI: 10.1002/alz.13447 |
0.369 |
|
| 2023 |
Su H, Masters CL, Bush AI, Barnham KJ, Reid GE, Vella LJ. Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles. Proteomics. e2300063. PMID 37654087 DOI: 10.1002/pmic.202300063 |
0.493 |
|
| 2023 |
Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS. Trial of Solanezumab in Preclinical Alzheimer's Disease. The New England Journal of Medicine. PMID 37458272 DOI: 10.1056/NEJMoa2305032 |
0.313 |
|
| 2023 |
Saint-Jalmes M, Fedyashov V, Beck D, Baldwin T, Faux NG, Bourgeat P, Fripp J, Masters CL, Goudey B. Disease Progression Modelling of Alzheimer's Disease using Probabilistic Principal Components Analysis. Neuroimage. 120279. PMID 37454702 DOI: 10.1016/j.neuroimage.2023.120279 |
0.318 |
|
| 2023 |
McKay NS, Gordon BA, Hornbeck RC, Dincer A, Flores S, Keefe SJ, Joseph-Mathurin N, Jack CR, Koeppe R, Millar PR, Ances BM, Chen CD, Daniels A, Hobbs DA, Jackson K, ... ... Masters CL, et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience. PMID 37429916 DOI: 10.1038/s41593-023-01359-8 |
0.465 |
|
| 2023 |
Lim YY, Yassi N, Bransby L, Ayton S, Buckley RF, Eratne D, Velakoulis D, Li QX, Fowler C, Masters CL, Maruff P. CSF Aβ and tau biomarkers in cognitively unimpaired Aβ- middle-aged and older APOE ε4 carriers. Neurobiology of Aging. 129: 209-218. PMID 37399739 DOI: 10.1016/j.neurobiolaging.2023.05.009 |
0.343 |
|
| 2023 |
Hampel H, Hu Y, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, et al. The amyloid-β pathway in Alzheimer's disease: a plain language summary. Neurodegenerative Disease Management. PMID 36994753 DOI: 10.2217/nmt-2022-0037 |
0.339 |
|
| 2023 |
Nho K, Risacher SL, Apostolova L, Bice PJ, Brosch J, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, ... ... Masters CL, et al. Novel Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PET. Medrxiv : the Preprint Server For Health Sciences. PMID 36993271 DOI: 10.1101/2023.02.27.23286048 |
0.338 |
|
| 2023 |
Roberts BR, Laffoon SB, Roberts AM, Porter T, Fowler C, Masters CL, Dratz EA, Laws SM. Discovery of a Missense Mutation (Q222K) of the Gene from the Australian Imaging, Biomarker and Lifestyle Study. Journal of Alzheimer's Disease Reports. 7: 165-172. PMID 36891255 DOI: 10.3233/ADR-220075 |
0.59 |
|
| 2023 |
Horie K, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, Ikeuchi T, Kasuga K, Noble J, ... ... Masters CL, et al. Change in cerebrospinal fluid tau microtubule binding region detects symptom onset, cognitive decline, tangles, and atrophy in Dominantly Inherited Alzheimer's Disease. Annals of Neurology. PMID 36843330 DOI: 10.1002/ana.26620 |
0.34 |
|
| 2023 |
Chatterjee P, Doré V, Pedrini S, Krishnadas N, Thota R, Bourgeat P, Ikonomovic MD, Rainey-Smith SR, Burnham SC, Fowler C, Taddei K, Mulligan R, Ames D, Masters CL, Fripp J, et al. Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36776057 DOI: 10.3233/JAD-220908 |
0.475 |
|
| 2023 |
Winston CN, Langford O, Levin N, Raman R, Yarasheski K, West T, Abdel-Latif S, Donohue M, Nakamura A, Toba K, Masters CL, Doecke J, Sperling RA, Aisen PS, Rissman RA. Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36710683 DOI: 10.3233/JAD-221118 |
0.334 |
|
| 2023 |
Krishnadas N, Doré V, Robertson JS, Ward L, Fowler C, Masters CL, Bourgeat P, Fripp J, Villemagne VL, Rowe CC. Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL F-MK6240 PET study. Ebiomedicine. 88: 104450. PMID 36709581 DOI: 10.1016/j.ebiom.2023.104450 |
0.337 |
|
| 2023 |
Sewell KR, Rainey-Smith SR, Peiffer J, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Martins RN, Erickson KI, Brown BM. The relationship between objective physical activity and change in cognitive function. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36656659 DOI: 10.1002/alz.12950 |
0.318 |
|
| 2022 |
Jiang Y, Zhou X, Wong HY, Ouyang L, Ip FCF, Chau VMN, Lau SF, Wu W, Wong DYK, Seo H, Fu WY, Lai NCH, Chen Y, Chen Y, Tong EPS, ... ... Masters CL, et al. An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease. Nature Aging. 2: 616-634. PMID 37117777 DOI: 10.1038/s43587-022-00241-9 |
0.346 |
|
| 2022 |
Chatterjee P, Vermunt L, Gordon BA, Pedrini S, Boonkamp L, Armstrong NJ, Xiong C, Singh AK, Li Y, Sohrabi HR, Taddei K, Molloy M, Benzinger TLS, Morris JC, Karch C, ... ... Masters CL, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36576155 DOI: 10.1002/alz.12879 |
0.52 |
|
| 2022 |
Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Doré V, Singh AK, Wang P, Rainey-Smith S, Fowler C, Taddei K, Sohrabi HR, Molloy MP, Ames D, Maruff P, ... ... Masters CL, et al. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36574591 DOI: 10.1002/alz.12724 |
0.529 |
|
| 2022 |
Dhiman K, Villemagne VL, Fowler C, Bourgeat P, Li QX, Collins S, Rowe CC, Masters CL, Ames D, Blennow K, Zetterberg H, Martins RN, Gupta V. Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12377. PMID 36479019 DOI: 10.1002/dad2.12377 |
0.441 |
|
| 2022 |
Fowler CJ, Stoops E, Rainey-Smith SR, Vanmechelen E, Vanbrabant J, Dewit N, Mauroo K, Maruff P, Rowe CC, Fripp J, Li QX, Bourgeat P, Collins SJ, Martins RN, Masters CL, et al. Plasma p-tau181/Aβ ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ and future cognitive decline. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12375. PMID 36447478 DOI: 10.1002/dad2.12375 |
0.506 |
|
| 2022 |
Huang X, Li Y, Fowler C, Doecke JD, Lim YY, Drysdale C, Zhang V, Park K, Trounson B, Pertile K, Rumble R, Pickering JW, Rissman RA, Sarsoza F, Abdel-Latif S, ... ... Masters CL, et al. Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36349985 DOI: 10.1002/alz.12813 |
0.493 |
|
| 2022 |
Mukherjee S, Dubois C, Perez K, Varghese S, Birchall IE, Leckey M, Davydova N, McLean C, Nisbet RM, Roberts BR, Li QX, Masters CL, Streltsov VA. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains. Journal of Neurochemistry. PMID 36271678 DOI: 10.1111/jnc.15713 |
0.75 |
|
| 2022 |
Sewell KR, Rainey-Smith SR, Villemagne VL, Peiffer J, Sohrabi HR, Taddei K, Ames D, Doré V, Maruff P, Laws SM, Masters CL, Rowe CC, Martins RN, Erickson KI, Brown BM. The interaction between physical activity and sleep on cognitive function and brain beta-amyloid in older adults. Behavioural Brain Research. 437: 114108. PMID 36100010 DOI: 10.1016/j.bbr.2022.114108 |
0.475 |
|
| 2022 |
Ruwanpathirana GP, Williams RC, Masters CL, Rowe CC, Johnston LA, Davey CE. Mapping the association between tau-PET and Aβ-amyloid-PET using deep learning. Scientific Reports. 12: 14797. PMID 36042256 DOI: 10.1038/s41598-022-18963-6 |
0.347 |
|
| 2022 |
Pedrini S, Doecke JD, Hone E, Wang P, Thota R, Bush AI, Rowe CC, Dore V, Villemagne VL, Ames D, Rainey-Smith S, Verdile G, Sohrabi HR, Raida MR, Taddei K, ... ... Masters CL, et al. Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. Journal of Neurochemistry. PMID 36000528 DOI: 10.1111/jnc.15681 |
0.557 |
|
| 2022 |
Poulakis K, Pereira JB, Muehlboeck JS, Wahlund LO, Smedby Ö, Volpe G, Masters CL, Ames D, Niimi Y, Iwatsubo T, Ferreira D, Westman E. Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's disease. Nature Communications. 13: 4566. PMID 35931678 DOI: 10.1038/s41467-022-32202-6 |
0.39 |
|
| 2022 |
Luo J, Agboola F, Grant E, Morris JC, Masters CL, Albert MS, Johnson SC, McDade EM, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Wang G, Li Y, et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology. PMID 35925685 DOI: 10.1093/brain/awac238 |
0.383 |
|
| 2022 |
Li Y, Huang X, Fowler C, Lim YY, Laws SM, Faux N, Doecke JD, Trounson B, Pertile K, Rumble R, Doré V, Villemagne VL, Rowe CC, Wiley JS, Maruff P, ... Masters CL, et al. Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's Disease. International Journal of Molecular Sciences. 23. PMID 35887215 DOI: 10.3390/ijms23147867 |
0.369 |
|
| 2022 |
Kellie JF, Campbell BCV, Watson R, Praeger AJ, Nair G, Murugasu A, Rowe CC, Masters CL, Collins S, McLean C, Yassi N. Amyloid-β (Aβ)-Related Cerebral Amyloid Angiopathy Causing Lobar Hemorrhage Decades After Childhood Neurosurgery. Stroke. 101161STROKEAHA12103. PMID 35770667 DOI: 10.1161/STROKEAHA.121.038364 |
0.348 |
|
| 2022 |
Cespedes M, Jacobs KR, Maruff P, Rembach A, Fowler CJ, Trounson B, Pertile KK, Rumble RL, Rainey-Smithe SR, Rowe CC, Villemagne VL, Bourgeat P, Lim CK, Chatterjee P, Martins RN, ... ... Masters CL, et al. Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β. Neurobiology of Disease. 171: 105783. PMID 35675895 DOI: 10.1016/j.nbd.2022.105783 |
0.488 |
|
| 2022 |
Cadby G, Giles C, Melton PE, Huynh K, Mellett NA, Duong T, Nguyen A, Cinel M, Smith A, Olshansky G, Wang T, Brozynska M, Inouye M, McCarthy NS, Ariff A, ... ... Masters CL, et al. Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease. Nature Communications. 13: 3124. PMID 35668104 DOI: 10.1038/s41467-022-30875-7 |
0.475 |
|
| 2022 |
Dhiman K, Villemagne VL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Blennow K, Zetterberg H, Martins RN, Gupta V. Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study. Biomedicines. 10. PMID 35625782 DOI: 10.3390/biomedicines10051045 |
0.555 |
|
| 2022 |
Vacher M, Doré V, Porter T, Milicic L, Villemagne VL, Bourgeat P, Burnham SC, Cox T, Masters CL, Rowe CC, Fripp J, Doecke JD, Laws SM. Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's disease. Bmc Genomics. 23: 401. PMID 35619096 DOI: 10.1186/s12864-022-08617-2 |
0.319 |
|
| 2022 |
Vöglein J, Franzmeier N, Morris JC, Dieterich M, McDade E, Simons M, Preische O, Hofmann A, Hassenstab J, Benzinger TL, Fagan A, Noble JM, Berman SB, Graff-Radford NR, Ghetti B, ... ... Masters CL, et al. Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35609137 DOI: 10.1002/alz.12684 |
0.459 |
|
| 2022 |
Morris JC, Weiner M, Xiong C, Beckett L, Coble D, Saito N, Aisen PS, Allegri R, Benzinger TLS, Berman SB, Cairns NJ, Carrillo MC, Chui HC, Chhatwal JP, Cruchaga C, ... ... Masters CL, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology. PMID 35580594 DOI: 10.1093/brain/awac181 |
0.559 |
|
| 2022 |
Milicic L, Vacher M, Porter T, Doré V, Burnham SC, Bourgeat P, Shishegar R, Doecke J, Armstrong NJ, Tankard R, Maruff P, Masters CL, Rowe CC, Villemagne VL, Laws SM. Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume. Geroscience. PMID 35445885 DOI: 10.1007/s11357-022-00558-8 |
0.328 |
|
| 2022 |
Mukherjee S, Fjeldsted JC, Masters CL, Roberts BR. Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software. Analytical and Bioanalytical Chemistry. PMID 35426495 DOI: 10.1007/s00216-022-04055-x |
0.74 |
|
| 2022 |
Pedrini S, Chatterjee P, Nakamura A, Tegg M, Hone E, Rainey-Smith SR, Rowe CC, Dore V, Villemagne VL, Ames D, Kaneko N, Gardener SL, Taddei K, Fernando B, Martins I, ... ... Masters CL, et al. The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults. Frontiers in Aging Neuroscience. 14: 771214. PMID 35418852 DOI: 10.3389/fnagi.2022.771214 |
0.528 |
|
| 2022 |
Doré V, Doecke JD, Saad ZS, Triana-Baltzer G, Slemmon R, Krishnadas N, Bourgeat P, Huang K, Burnham S, Fowler C, Rainey-Smith SR, Bush AI, Ward L, Robertson J, Martins RN, ... Masters CL, et al. Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12307. PMID 35415202 DOI: 10.1002/dad2.12307 |
0.552 |
|
| 2022 |
Krishnadas N, Doré V, Groot C, Lamb F, Bourgeat P, Burnham SC, Huang K, Goh AMY, Masters CL, Villemagne VL, Rowe CC. Mesial temporal tau in amyloid-β-negative cognitively normal older persons. Alzheimer's Research & Therapy. 14: 51. PMID 35395950 DOI: 10.1186/s13195-022-00993-x |
0.331 |
|
| 2022 |
Woodfield A, Porter T, Gilani I, Noordin S, Li QX, Collins S, Martins RN, Maruff P, Masters CL, Rowe CC, Villemagne VL, Dore V, Newsholme P, Laws SM, Verdile G. Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF Aβ42 moderates the association between insulin resistance and increased CSF tau levels. Neurobiology of Aging. 114: 38-48. PMID 35381406 DOI: 10.1016/j.neurobiolaging.2022.03.004 |
0.479 |
|
| 2022 |
Bu XL, Sun PY, Fan DY, Wang J, Sun HL, Cheng Y, Zeng GH, Chen DW, Li HY, Yi X, Shen YY, Miles LA, Maruff P, Gu BJ, Fowler CJ, ... Masters CL, et al. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease. Science Advances. 8: eabm5667. PMID 35363517 DOI: 10.1126/sciadv.abm5667 |
0.405 |
|
| 2022 |
Luckett PH, Chen C, Gordon BA, Wisch J, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, Fox NC, Jucker M, Levin J, Masters CL, Mori H, Noble JM, et al. Biomarker clustering in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35362200 DOI: 10.1002/alz.12661 |
0.35 |
|
| 2022 |
Rosenich E, Bransby L, Yassi N, Fripp J, Laws SM, Martins RN, Fowler C, Rainey-Smith SR, Rowe CC, Masters CL, Maruff P, Lim YY. Differential Effects of APOE and Modifiable Risk Factors on Hippocampal Volume Loss and Memory Decline in AB- and AB+ Older Adults. Neurology. PMID 35169009 DOI: 10.1212/WNL.0000000000200118 |
0.41 |
|
| 2022 |
Guévremont D, Tsui H, Knight R, Fowler CJ, Masters CL, Martins RN, Abraham WC, Tate WP, Cutfield NJ, Williams JM. Plasma microRNA vary in association with the progression of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12251. PMID 35141392 DOI: 10.1002/dad2.12251 |
0.481 |
|
| 2022 |
Lim YY, Maruff P, Barthélemy NR, Goate A, Hassenstab J, Sato C, Fagan AM, Benzinger TLS, Xiong C, Cruchaga C, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, et al. Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. Jama Neurology. PMID 35099506 DOI: 10.1001/jamaneurol.2021.5181 |
0.313 |
|
| 2022 |
Laffoon SB, Doecke JD, Roberts AM, Vance JA, Reeves BD, Pertile KK, Rumble RL, Fowler CJ, Trounson B, Ames D, Martins R, Bush AI, Masters CL, Grieco PA, Dratz EA, et al. Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease. Proteome Science. 20: 2. PMID 35081972 DOI: 10.1186/s12953-021-00185-9 |
0.721 |
|
| 2022 |
Wang T, Huynh K, Giles C, Mellett NA, Duong T, Nguyen A, Lim WLF, Smith AA, Olshansky G, Cadby G, Hung J, Hui J, Beilby J, Watts GF, Chatterjee P, ... ... Masters CL, et al. APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35077012 DOI: 10.1002/alz.12538 |
0.578 |
|
| 2022 |
Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... ... Masters CL, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6 |
0.531 |
|
| 2022 |
Pavlik VN, Burnham SC, Kass JS, Helmer C, Palmqvist S, Vassilaki M, Dartigues JF, Hansson O, Masters CL, Pérès K, Petersen RC, Stomrud E, Butler L, Coloma PM, Teitsma XM, et al. Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network. Journal of Alzheimer's Disease : Jad. 85: 31-45. PMID 34776434 DOI: 10.3233/JAD-210525 |
0.319 |
|
| 2021 |
Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot-Corbel E, Bjerke M, Blanc-Quintin MC, Boada M, Bousiges O, Chapman MD, ... ... Masters CL, et al. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34936194 DOI: 10.1002/alz.12545 |
0.333 |
|
| 2021 |
Li Y, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Weiner MW, Leslie SM, Masters CL, Fowler CJ, Trojanowski JQ, Korecka M, Martins RN, Janelidze S, Hansson O, Bateman RJ. Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology. PMID 34906975 DOI: 10.1212/WNL.0000000000013211 |
0.52 |
|
| 2021 |
Gardener SL, Rainey-Smith SR, Villemagne VL, Fripp J, Doré V, Bourgeat P, Taddei K, Fowler C, Masters CL, Maruff P, Rowe CC, Ames D, Martins RN. Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study. Frontiers in Aging Neuroscience. 13: 744872. PMID 34867277 DOI: 10.3389/fnagi.2021.744872 |
0.491 |
|
| 2021 |
Buckles VD, Xiong C, Bateman RJ, Hassenstab J, Allegri R, Berman SB, Chhatwal JP, Danek A, Fagan AM, Ghetti B, Goate A, Graff-Radford N, Jucker M, Levin J, Marcus DS, ... Masters CL, et al. Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34854530 DOI: 10.1002/alz.12505 |
0.412 |
|
| 2021 |
Li Y, Laws SM, Miles LA, Wiley JS, Huang X, Masters CL, Gu BJ. Genomics of Alzheimer's disease implicates the innate and adaptive immune systems. Cellular and Molecular Life Sciences : Cmls. PMID 34708251 DOI: 10.1007/s00018-021-03986-5 |
0.363 |
|
| 2021 |
Klatt S, Doecke JD, Roberts A, Boughton BA, Masters CL, Horne M, Roberts BR. A six-metabolite panel as potential blood-based biomarkers for Parkinson's disease. Npj Parkinson's Disease. 7: 94. PMID 34650080 DOI: 10.1038/s41531-021-00239-x |
0.593 |
|
| 2021 |
Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL, Wilkins S, Shackleford DM, Charman SA, Bal W, Zawisza IA, Kurowska E, Gundlach AL, Ma S, Bush AI, et al. Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta Neuropathologica Communications. 9: 161. PMID 34588001 DOI: 10.1186/s40478-021-01258-8 |
0.392 |
|
| 2021 |
McDade E, Voytyuk I, Aisen P, Bateman RJ, Carrillo MC, De Strooper B, Haass C, Reiman EM, Sperling R, Tariot PN, Yan R, Masters CL, Vassar R, Lichtenthaler SF. The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. Nature Reviews. Neurology. PMID 34548654 DOI: 10.1038/s41582-021-00545-1 |
0.336 |
|
| 2021 |
Mukherjee S, Perez KA, Dubois C, Nisbet RM, Li QX, Varghese S, Jin L, Birchall I, Streltsov VA, Vella LJ, McLean C, Barham KJ, Roberts BR, Masters CL. Citrullination of Amyloid-β Peptides in Alzheimer's Disease. Acs Chemical Neuroscience. PMID 34519476 DOI: 10.1021/acschemneuro.1c00474 |
0.765 |
|
| 2021 |
Chatterjee P, Pedrini S, Ashton NJ, Tegg M, Goozee K, Singh AK, Karikari TK, Simrén J, Vanmechelen E, Armstrong NJ, Hone E, Asih PR, Taddei K, Doré V, Villemagne VL, ... ... Masters CL, et al. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34494715 DOI: 10.1002/alz.12447 |
0.494 |
|
| 2021 |
Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A. The Amyloid-β Pathway in Alzheimer's Disease. Molecular Psychiatry. PMID 34456336 DOI: 10.1038/s41380-021-01249-0 |
0.38 |
|
| 2021 |
Huq AJ, Fulton-Howard B, Riaz M, Laws S, Sebra R, Ryan J, Renton AE, Goate AM, Masters CL, Storey E, Shah RC, Murray A, McNeil J, Winship I, et al. Polygenic score modifies risk for Alzheimer's disease in ε4 homozygotes at phenotypic extremes. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12226. PMID 34386572 DOI: 10.1002/dad2.12226 |
0.36 |
|
| 2021 |
Fowler C, Rainey-Smith SR, Bird S, Bomke J, Bourgeat P, Brown BM, Burnham SC, Bush AI, Chadunow C, Collins S, Doecke J, Doré V, Ellis KA, Evered L, Fazlollahi A, ... ... Masters CL, et al. Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's Disease. Journal of Alzheimer's Disease Reports. 5: 443-468. PMID 34368630 DOI: 10.3233/ADR-210005 |
0.611 |
|
| 2021 |
Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, ... ... Masters CL, et al. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 20: 615-626. PMID 34302786 DOI: 10.1016/S1474-4422(21)00139-3 |
0.482 |
|
| 2021 |
Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, ... ... Masters CL, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197 |
0.465 |
|
| 2021 |
Sexton CE, Anstey KJ, Baldacci F, Barnum CJ, Barron AM, Blennow K, Brodaty H, Burnham S, Elahi FM, Götz J, Jeon YH, Koronyo-Hamaoui M, Landau SM, Lautenschlager NT, Laws SM, ... ... Masters CL, et al. Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34058063 DOI: 10.1002/alz.12380 |
0.336 |
|
| 2021 |
Pichet Binette A, Theaud G, Rheault F, Roy M, Collins DL, Levin J, Mori H, Lee JH, Farlow MR, Schofield P, Chhatwal JP, Masters CL, Benzinger T, Morris J, Bateman R, et al. Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease. Elife. 10. PMID 33983116 DOI: 10.7554/eLife.62929 |
0.402 |
|
| 2021 |
Gardener SL, Weinborn M, Sohrabi HR, Doecke JD, Bourgeat P, Rainey-Smith SR, Shen KK, Fripp J, Taddei K, Maruff P, Salvado O, Savage G, Ames D, Masters CL, Rowe CC, et al. Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults. Journal of Alzheimer's Disease : Jad. 81: 1039-1052. PMID 33935071 DOI: 10.3233/JAD-201243 |
0.348 |
|
| 2021 |
Mukherjee S, Perez KA, Lago LC, Klatt S, McLean CA, Birchall IE, Barnham KJ, Masters CL, Roberts BR. Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease. Brain Communications. 3: fcab028. PMID 33928245 DOI: 10.1093/braincomms/fcab028 |
0.74 |
|
| 2021 |
Doecke JD, Francois C, Fowler CJ, Stoops E, Bourgeat P, Rainey-Smith SR, Li QX, Masters CL, Martins RN, Villemagne VL, Collins SJ, Vanderstichele HM. Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods. Alzheimer's Research & Therapy. 13: 79. PMID 33863377 DOI: 10.1186/s13195-021-00812-9 |
0.376 |
|
| 2021 |
Chatterjee P, Tegg M, Pedrini S, Fagan AM, Xiong C, Singh AK, Taddei K, Gardener S, Masters CL, Schofield PR, Multhaup G, Benzinger TLS, Morris JC, Bateman RJ, Greenberg SM, et al. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation. International Journal of Molecular Sciences. 22. PMID 33805778 DOI: 10.3390/ijms22062931 |
0.776 |
|
| 2021 |
Fernandez S, Burnham SC, Milicic L, Savage G, Maruff P, Peretti M, Sohrabi HR, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. Is Associated with Amyloid-β and ε4-Related Cognitive Decline in Cognitively Normal Adults. Journal of Alzheimer's Disease Reports. 5: 111-120. PMID 33782664 DOI: 10.3233/ADR-200246 |
0.383 |
|
| 2021 |
Lim YY, Baker JE, Mills A, Bruns L, Fowler C, Fripp J, Rainey-Smith SR, Ames D, Masters CL, Maruff P. Learning deficit in cognitively normal APOE ε4 carriers with LOW β-amyloid. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12136. PMID 33748392 DOI: 10.1002/dad2.12136 |
0.308 |
|
| 2021 |
Moussavi Nik SH, Porter T, Newman M, Bartlett B, Khan I, Sabale M, Eccles M, Woodfield A, Groth D, Dore V, Villemagne VL, Masters CL, Martins RN, Laws SM, Lardelli M, et al. Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration. Journal of Alzheimer's Disease : Jad. PMID 33720885 DOI: 10.3233/JAD-201133 |
0.615 |
|
| 2021 |
Tan S, Porter T, Bucks RS, Weinborn M, Milicic L, Brown A, Rainey-Smith SR, Taddei K, Ames D, Masters CL, Maruff P, Savage G, Rowe CC, Villemagne VL, Brown B, et al. Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition. Hormones and Behavior. 131: 104966. PMID 33714752 DOI: 10.1016/j.yhbeh.2021.104966 |
0.358 |
|
| 2021 |
Steward CE, Venkatraman VK, Lui E, Malpas CB, Ellis KA, Cyarto EV, Vivash L, O'Brien TJ, Velakoulis D, Ames D, Masters CL, Lautenschlager NT, Bammer R, Desmond PM. Assessment of the DTI-ALPS Parameter Along the Perivascular Space in Older Adults at Risk of Dementia. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 33556226 DOI: 10.1111/jon.12837 |
0.313 |
|
| 2021 |
Liu YH, Wang J, Li QX, Fowler CJ, Zeng F, Deng J, Xu ZQ, Zhou HD, Doecke JD, Villemagne VL, Lim YY, Masters CL, Wang YJ. Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer's disease. Science Advances. 7. PMID 33523832 DOI: 10.1126/sciadv.abb0457 |
0.408 |
|
| 2021 |
Doré V, Krishnadas N, Bourgeat P, Huang K, Li S, Burnham S, Masters CL, Fripp J, Villemagne VL, Rowe CC. Relationship between amyloid and tau levels and its impact on tau spreading. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33495928 DOI: 10.1007/s00259-021-05191-9 |
0.335 |
|
| 2020 |
Lim YY, Laws SM, Perin S, Pietrzak RH, Fowler C, Masters CL, Maruff P. BDNF VAL66MET Polymorphism and Memory Decline Across the Spectrum of Alzheimer's Disease. Genes, Brain, and Behavior. e12724. PMID 33369083 DOI: 10.1111/gbb.12724 |
0.349 |
|
| 2020 |
Chatterjee P, Fagan AM, Xiong C, McKay M, Bhatnagar A, Wu Y, Singh AK, Taddei K, Martins I, Gardener SL, Molloy MP, Multhaup G, Masters CL, Schofield PR, Benzinger TLS, et al. Presymptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy-Related Blood Metabolite Alterations. Journal of Alzheimer's Disease : Jad. PMID 33361604 DOI: 10.3233/JAD-201267 |
0.757 |
|
| 2020 |
Chin KS, Yassi N, Churilov L, Masters CL, Watson R. Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis. Parkinsonism & Related Disorders. 80: 184-193. PMID 33260030 DOI: 10.1016/j.parkreldis.2020.09.030 |
0.316 |
|
| 2020 |
van der Kall LM, Truong T, Burnham SC, Doré V, Mulligan RS, Bozinovski S, Lamb F, Bourgeat P, Fripp J, Schultz S, Lim YY, Laws SM, Ames D, Fowler C, Rainey-Smith SR, ... ... Masters CL, et al. Association of β-amyloid level, clinical progression and longitudinal cognitive change in normal older individuals. Neurology. PMID 33184233 DOI: 10.1212/WNL.0000000000011222 |
0.415 |
|
| 2020 |
Huynh K, Lim WLF, Giles C, Jayawardana KS, Salim A, Mellett NA, Smith AAT, Olshansky G, Drew BG, Chatterjee P, Martins I, Laws SM, Bush AI, Rowe CC, Villemagne VL, ... ... Masters CL, et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease. Nature Communications. 11: 5698. PMID 33173055 DOI: 10.1038/s41467-020-19473-7 |
0.572 |
|
| 2020 |
Xia Y, Yassi N, Raniga P, Bourgeat P, Desmond P, Doecke J, Ames D, Laws SM, Fowler C, Rainey-Smith SR, Martins R, Maruff P, Villemagne VL, Masters CL, Rowe CC, et al. Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging. Journal of Alzheimer's Disease : Jad. PMID 32986666 DOI: 10.3233/JAD-200419 |
0.52 |
|
| 2020 |
Lim YY, Maruff P, Kaneko N, Doecke J, Fowler C, Villemagne VL, Kato T, Rowe CC, Arahata Y, Iwamoto S, Ito K, Tanaka K, Yanagisawa K, Masters CL, Nakamura A. Plasma Amyloid-β Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32925048 DOI: 10.3233/Jad-200475 |
0.306 |
|
| 2020 |
Cheng L, Vella LJ, Barnham KJ, McLean C, Masters CL, Hill AF. Small RNA fingerprinting of Alzheimer's disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles. Journal of Extracellular Vesicles. 9: 1766822. PMID 32922692 DOI: 10.1080/20013078.2020.1766822 |
0.347 |
|
| 2020 |
Luo J, Agboola F, Grant E, Masters CL, Albert MS, Johnson SC, McDade EM, Vöglein J, Fagan AM, Benzinger T, Massoumzadeh P, Hassenstab J, Bateman RJ, Morris JC, Perrin RJ, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: A cross-sectional study. Neurology. PMID 32873693 DOI: 10.1212/Wnl.0000000000010747 |
0.423 |
|
| 2020 |
Siddiqui MS, Francois M, Rainey-Smith S, Martins R, Masters CL, Ames D, Rowe CC, Macaulay LS, Fenech MF, Leifert WR. Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer's Disease in the AIBL Study of Ageing. Life (Basel, Switzerland). 10. PMID 32781776 DOI: 10.3390/Life10080141 |
0.466 |
|
| 2020 |
Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 32772959 DOI: 10.1017/S135561772000079X |
0.506 |
|
| 2020 |
Burnham SC, Laws SM, Budgeon CA, Doré V, Porter T, Bourgeat P, Buckley RF, Murray K, Ellis KA, Turlach BA, Salvado O, Ames D, Martins RN, Rentz D, Masters CL, et al. Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition. Neurobiology of Aging. 95: 46-55. PMID 32750666 DOI: 10.1016/J.Neurobiolaging.2020.06.001 |
0.574 |
|
| 2020 |
Pedrini S, Hone E, Gupta VB, James I, Teimouri E, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Rainey-Smith S, Verdile G, Sohrabi HR, Raida MR, Wenk MR, et al. Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance. Journal of Alzheimer's Disease : Jad. PMID 32741823 DOI: 10.3233/Jad-200291 |
0.611 |
|
| 2020 |
Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J, Flores S, Keefe S, Dincer A, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal J, Cruchaga C, ... ... Masters C, et al. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiology of Disease. 104960. PMID 32522711 DOI: 10.1016/J.Nbd.2020.104960 |
0.326 |
|
| 2020 |
Ashraf A, Ashton NJ, Chatterjee P, Goozee K, Shen K, Fripp J, Ames D, Rowe C, Masters CL, Villemagne V, Hye A, Martins RN, So PW. Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology. Alzheimer's Research & Therapy. 12: 72. PMID 32517787 DOI: 10.1186/S13195-020-00634-1 |
0.565 |
|
| 2020 |
Lim WLF, Huynh K, Chatterjee P, Martins I, Jayawardana KS, Giles C, Mellett NA, Laws SM, Bush AI, Rowe CC, Villemagne VL, Ames D, Drew BG, Masters CL, Meikle PJ, et al. Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32474467 DOI: 10.3233/Jad-191304 |
0.639 |
|
| 2020 |
Lim B, Li QX, Rowe C, Dhiman K, Gupta VB, Masters CL, Doecke JD, Martins RN, Collins S, Diamandis EP. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease. Neuroscience Letters. 135078. PMID 32450185 DOI: 10.1016/J.Neulet.2020.135078 |
0.57 |
|
| 2020 |
Wu HZY, Thalamuthu A, Cheng L, Fowler C, Masters CL, Sachdev P, Mather KA. Differential blood miRNA expression in brain amyloid imaging-defined Alzheimer's disease and controls. Alzheimer's Research & Therapy. 12: 59. PMID 32414413 DOI: 10.1186/S13195-020-00627-0 |
0.382 |
|
| 2020 |
Panegyres PK, Stehmann C, Klug GM, Masters CL, Collins S. Prion disease in Indigenous Australians. Internal Medicine Journal. PMID 32237029 DOI: 10.1111/Imj.14835 |
0.403 |
|
| 2020 |
Doecke JD, Ward L, Burnham SC, Villemagne VL, Li QX, Collins S, Fowler CJ, Manuilova E, Widmann M, Rainey-Smith SR, Martins RN, Masters CL. Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging. Alzheimer's Research & Therapy. 12: 36. PMID 32234072 DOI: 10.1186/s13195-020-00595-5 |
0.472 |
|
| 2020 |
Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Hone E, Blennow K, et al. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12005. PMID 32211500 DOI: 10.1002/Dad2.12005 |
0.633 |
|
| 2020 |
Doecke JD, Pérez-Grijalba V, Fandos N, Fowler C, Villemagne VL, Masters CL, Pesini P, Sarasa M. Total Aβ/Aβ ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis. Neurology. PMID 32179698 DOI: 10.1212/WNL.0000000000009240 |
0.332 |
|
| 2020 |
Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, ... ... Masters CL, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z |
0.564 |
|
| 2020 |
Amadoru S, Doré V, McLean CA, Hinton F, Shepherd CE, Halliday GM, Leyton CE, Yates PA, Hodges JR, Masters CL, Villemagne VL, Rowe CC. Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease. Alzheimer's Research & Therapy. 12: 22. PMID 32131891 DOI: 10.1186/S13195-020-00587-5 |
0.392 |
|
| 2020 |
Franzmeier N, Koutsouleris N, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Duering M, Dichgans M, Levin J, Gordon BA, Lim YY, Masters CL, Rossor M, Fox NC, et al. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043733 DOI: 10.1002/Alz.12032 |
0.341 |
|
| 2020 |
Klatt S, Roberts A, Lothian A, Masters CL, Cappai R, Fowler C, Roberts BR. Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometry. Analytical and Bioanalytical Chemistry. PMID 32030493 DOI: 10.1007/s00216-020-02439-5 |
0.544 |
|
| 2020 |
Lai MMY, Sharman MJ, Ames DJ, Ellis KA, Cox KL, Hepworth G, Desmond P, Cyarto EV, Martins RN, Masters CL, Lautenschlager NT. Relationship of Established Cardiovascular Risk Factors and Peripheral Biomarkers on Cognitive Function in Adults at Risk of Cognitive Deterioration. Journal of Alzheimer's Disease : Jad. PMID 32007955 DOI: 10.3233/JAD-190953 |
0.334 |
|
| 2020 |
Aschenbrenner AJ, James BD, McDade E, Wang G, Lim YY, Benzinger TLS, Cruchaga C, Goate A, Xiong C, Perrin R, Buckles V, Allegri R, Berman SB, Chhatwal JP, Fagan A, ... ... Masters C, et al. Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 219-228. PMID 31914221 DOI: 10.1002/Alz.12010 |
0.389 |
|
| 2019 |
Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe C, Villemagne V, Salvado O, ... ... Masters CL, et al. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31884485 DOI: 10.3233/Jad-191028 |
0.509 |
|
| 2019 |
Hata S, Omori C, Kimura A, Saito H, Kimura N, Gupta V, Pedrini S, Hone E, Chatterjee P, Taddei K, Kasuga K, Ikeuchi T, Waragai M, Nishimura M, Hu A, ... ... Masters CL, et al. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 740-750. PMID 31754625 DOI: 10.1016/J.Trci.2019.09.015 |
0.548 |
|
| 2019 |
Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM. Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition. Scientific Reports. 9: 17069. PMID 31745181 DOI: 10.1038/S41598-019-53604-5 |
0.544 |
|
| 2019 |
Burnham SC, Coloma PM, Li QX, Collins S, Savage G, Laws S, Doecke J, Maruff P, Martins RN, Ames D, Rowe CC, Masters CL, Villemagne VL. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study. The Journal of Prevention of Alzheimer's Disease. 6: 248-255. PMID 31686097 DOI: 10.14283/jpad.2019.25 |
0.514 |
|
| 2019 |
Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C, Villemagne VL, Taylor EN, Fluke C, Soucy JP, Lesage F, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease. Nature Communications. 10: 4227. PMID 31530809 DOI: 10.1038/S41467-019-12242-1 |
0.448 |
|
| 2019 |
Huq AJ, Fransquet P, Laws SM, Ryan J, Sebra R, Masters CL, Winship IM, James PA, Lacaze P. Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506248 DOI: 10.1016/J.Jalz.2019.05.011 |
0.342 |
|
| 2019 |
Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/J.Jalz.2019.06.4955 |
0.358 |
|
| 2019 |
Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, Palmqvist S, Masters CL, Maruff PT, Hansson O, Mattsson N. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. PMID 31289148 DOI: 10.1212/Wnl.0000000000007831 |
0.32 |
|
| 2019 |
Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V, Fripp J, Ames D, Masters CL, Rowe CC, Connelly A, Villemagne VL, Salvado O. Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease. Journal of Magnetic Resonance Imaging : Jmri. PMID 31145515 DOI: 10.1002/Jmri.26810 |
0.323 |
|
| 2019 |
Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S. Comparison of F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL approaches: Validation against histopathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31101517 DOI: 10.1016/J.Jalz.2019.02.005 |
0.341 |
|
| 2019 |
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. val158met is not associated with Aβ-amyloid and ε4 related cognitive decline in cognitively normal older adults. Ibro Reports. 6: 147-152. PMID 31080907 DOI: 10.1016/J.Ibror.2019.05.001 |
0.433 |
|
| 2019 |
Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 1-10. PMID 30924399 DOI: 10.1080/13803395.2019.1593949 |
0.388 |
|
| 2019 |
Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, ... ... Masters CL, et al. The BDNF SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. Molecular Psychiatry. PMID 30899092 DOI: 10.1038/S41380-019-0404-6 |
0.44 |
|
| 2019 |
Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, ... ... Masters CL, et al. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease. Science Advances. 5: eaau7220. PMID 30775436 DOI: 10.1126/Sciadv.Aau7220 |
0.665 |
|
| 2019 |
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 76: 162-165. PMID 30716541 DOI: 10.1016/J.Neurobiolaging.2018.12.014 |
0.482 |
|
| 2019 |
Villemagne VL, Velakoulis D, Doré V, Bozinoski S, Masters CL, Rowe CC, Walterfang M. Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30690666 DOI: 10.1007/s00259-019-4273-7 |
0.332 |
|
| 2019 |
Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nature Medicine. PMID 30664784 DOI: 10.1038/S41591-018-0304-3 |
0.459 |
|
| 2019 |
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Peretti M, Sohrabi HR, Lim YYY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith SR, Rowe C, Salvado O, et al. P4-485: SPON1 is associated with Aβ-Amyloid and APOE ε4 related cognitive decline in cognitively normal adults Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.08.031 |
0.393 |
|
| 2019 |
Yassi N, Dang C, Fazlollahi A, Xia Y, Watson R, Maruff P, Salvado O, Fripp J, Villemagne VL, Rowe CC, Masters CL. P1-352: WHITE MATTER HYPERINTENSITIES, AMYLOID-β, AND RISK OF COGNITIVE DECLINE IN HEALTHY OLDER PEOPLE Alzheimer's & Dementia. 15: P385-P386. DOI: 10.1016/J.Jalz.2019.06.907 |
0.334 |
|
| 2019 |
Rowe CC, Dore V, Mulligan RS, Tyrrell R, Guzman R, Lamb F, Bourgeat P, Fripp J, Masters CL, Villemagne VL. O5‐01‐05: Tau Imaging With 18F‐Mk6240 In Alzheimer'S Disease And Other Dementias Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4838 |
0.458 |
|
| 2019 |
Villemagne VL, Burnham SC, Bourgeat P, Dore V, Laws SM, Fripp J, Martins RN, Masters CL, Rowe CC. ASSESSING GLOBAL AND REGIONAL Aβ-AMYLOID DEPOSITION IN THE BRAIN WITH MULTIPLE Aβ-TRACERS USING THE CENTILOID SCALE Alzheimers & Dementia. 15: 219. DOI: 10.1016/J.Jalz.2019.06.4571 |
0.409 |
|
| 2019 |
Burnham SC, Fandos N, Fowler C, Pérez-Grijalba V, Dore V, Doecke JD, Sarasa M, Fripp J, Rowe C, Masters CL, Pesini P, Villemagne VL. LONGITUDINAL EVALUATION OF THE NATURAL HISTORY OF Aβ IN PLASMA AND BRAIN Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4553 |
0.343 |
|
| 2019 |
Masters CL, Nakamura A, Yanagisawa K, Huang X, Gu BJ, Villemagne VL, Barnham KJ, Perez K, Vella L, Li Q, Roberts BR, Fowler C. F2-07-02: RECENT FINDINGS OF NOVEL BLOOD COMPONENTS’ AMYLOID-BETA MEASURES Alzheimer's & Dementia. 15: P526-P527. DOI: 10.1016/J.Jalz.2019.06.4441 |
0.607 |
|
| 2019 |
Martins RN, Chatterjee P, Masters CL, Zetterberg H, Blennow K, Nakamura A, Yanagisawa K. PATIENT-RELATED PRE-ANALYTICAL FACTORS INFLUENCING PLASMA AMYLOID BETA CONCENTRATIONS Alzheimer's & Dementia. 15: P185. DOI: 10.1016/J.Jalz.2019.06.4386 |
0.464 |
|
| 2019 |
Kall LMvD, Burnham SC, Dore V, Mulligan RS, Bozinovski S, Bourgeat P, Tyrrell R, Young K, Fripp J, Masters CL, Villemagne VL, Rowe C. Ic-P-017: Amyloid Pet Is More Than Just Positive Or Negative: Amyloid Level Impacts Risk Of Clinical Progression In Normal Individuals Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4179 |
0.353 |
|
| 2019 |
Chin KS, Yassi N, Masters CL, Watson R. P4-341: THE PREVALENCE AND INFLUENCE OF TAU IN LEWY BODY DEMENTIA Alzheimer's & Dementia. 15: P1428-P1428. DOI: 10.1016/J.Jalz.2019.06.4011 |
0.331 |
|
| 2019 |
Papp KV, Buckley RF, Mormino EC, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio R. P3-031: CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER'S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID Alzheimer's & Dementia. 15: P937-P938. DOI: 10.1016/J.Jalz.2019.06.3057 |
0.38 |
|
| 2019 |
Yassi N, Chin KS, Vidaurre L, Villemagne VL, Rowe CC, Masters CL, Watson R. P2-328: THE LEWY STUDY: AN AUSTRALIAN LONGITUDINAL COHORT STUDY OF DEMENTIA WITH LEWY BODIES Alzheimer's & Dementia. 15: P713-P714. DOI: 10.1016/J.Jalz.2019.06.2735 |
0.307 |
|
| 2018 |
Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, et al. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 423. PMID 30620773 DOI: 10.3389/Fnagi.2018.00423 |
0.41 |
|
| 2018 |
Suárez-Calvet M, Capell A, Araque Caballero MÁ, Morenas-Rodríguez E, Fellerer K, Franzmeier N, Kleinberger G, Eren E, Deming Y, Piccio L, Karch CM, Cruchaga C, Paumier K, Bateman RJ, Fagan AM, ... ... Masters CL, et al. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine. PMID 30482868 DOI: 10.15252/Emmm.201809712 |
0.389 |
|
| 2018 |
Lothian A, Lago L, Mukherjee S, Connor AR, Fowler C, McLean CA, Horne M, Masters CL, Cappai R, Roberts BR. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn. Metallomics : Integrated Biometal Science. PMID 30465671 DOI: 10.1039/C8Mt00223A |
0.685 |
|
| 2018 |
Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Li QX, Ames D, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. Journal of Alzheimer's Disease : Jad. PMID 30412495 DOI: 10.3233/Jad-180713 |
0.311 |
|
| 2018 |
Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, et al. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Translational Psychiatry. 8: 238. PMID 30375373 DOI: 10.1038/S41398-018-0293-5 |
0.51 |
|
| 2018 |
Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C, Jagust WJ, Jin LW, Klunk WE, ... ... Masters CL, et al. Multisite study of the relationships between antemortem [C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30347188 DOI: 10.1016/J.Jalz.2018.09.001 |
0.34 |
|
| 2018 |
Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews. Neurology. PMID 30297701 DOI: 10.1038/S41582-018-0079-7 |
0.304 |
|
| 2018 |
Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith SR, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, ... Masters CL, et al. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 30272115 DOI: 10.1093/Arclin/Acy078 |
0.369 |
|
| 2018 |
Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, ... ... Masters CL, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30266303 DOI: 10.1016/J.Jalz.2018.06.3059 |
0.509 |
|
| 2018 |
McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, ... ... Masters C, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277 |
0.329 |
|
| 2018 |
Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith S, Robertson J, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Rowe CC, ... Masters CL, et al. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 30149452 DOI: 10.3233/Jad-180507 |
0.418 |
|
| 2018 |
Dehghani C, Frost S, Jayasena R, Masters CL, Kanagasingam Y. Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions. Investigative Ophthalmology & Visual Science. 59: 3554-3563. PMID 30025102 DOI: 10.1167/Iovs.18-24694 |
0.428 |
|
| 2018 |
Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, McDade E, Chhatwal J, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield P, et al. Effect of BDNFVal66Met on disease markers in dominantly inherited AD. Annals of Neurology. PMID 30014553 DOI: 10.1002/Ana.25299 |
0.444 |
|
| 2018 |
Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, et al. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29803541 DOI: 10.1016/J.Jalz.2018.04.010 |
0.446 |
|
| 2018 |
Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, ... Masters CL, et al. Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study. Psychological Assessment. PMID 29781669 DOI: 10.1037/pas0000565 |
0.467 |
|
| 2018 |
Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Burnham SC, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL. Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 29758940 DOI: 10.3233/JAD-170998 |
0.438 |
|
| 2018 |
Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Masters CL, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/Journal.Pone.0195838 |
0.57 |
|
| 2018 |
Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, ... ... Masters CL, et al. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease : Jad. 62: 965-992. PMID 29562546 DOI: 10.3233/Jad-171145 |
0.629 |
|
| 2018 |
Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years. Alzheimer Disease and Associated Disorders. PMID 29561277 DOI: 10.1097/WAD.0000000000000252 |
0.494 |
|
| 2018 |
Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Masters CL, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/Brain/Awy053 |
0.481 |
|
| 2018 |
Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, et al. Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. Translational Psychiatry. 8: 47. PMID 29479071 DOI: 10.1038/s41398-018-0094-x |
0.402 |
|
| 2018 |
Franzmeier N, Düzel E, Jessen F, Buerger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, et al. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease. Brain : a Journal of Neurology. PMID 29462334 DOI: 10.1093/Brain/Awy008 |
0.445 |
|
| 2018 |
Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nature Reviews. Neurology. PMID 29449700 DOI: 10.1038/nrneurol.2018.9 |
0.396 |
|
| 2018 |
Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, ... ... Masters CL, et al. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature. 554: 249-254. PMID 29420472 DOI: 10.1038/Nature25456 |
0.555 |
|
| 2018 |
Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR, ... ... Masters CL, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. The Lancet. Neurology. PMID 29397305 DOI: 10.1016/S1474-4422(18)30028-0 |
0.346 |
|
| 2018 |
Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, et al. KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden. Scientific Reports. 8: 2034. PMID 29391469 DOI: 10.1038/S41598-018-20513-Y |
0.582 |
|
| 2018 |
Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, ... ... Masters CL, et al. Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β. Journal of Alzheimer's Disease : Jad. 61: 1589-1598. PMID 29376865 DOI: 10.3233/JAD-170742 |
0.47 |
|
| 2018 |
Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. Jama Neurology. PMID 29356823 DOI: 10.1001/jamaneurol.2017.4325 |
0.487 |
|
| 2018 |
Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease. Journal of Affective Disorders. 229: 269-274. PMID 29329059 DOI: 10.1016/j.jad.2017.12.101 |
0.494 |
|
| 2018 |
Fazlollahi A, Calamante F, Liang X, Bourgeat P, Dore V, Raniga P, Fripp J, Ames D, Masters CL, Rowe C, Connelly A, Villemagne VL, Salvado O, (Aibl) L. P1-440: Increased Cerebral Blood Flow With Increased Amyloid Burden In Preclinical Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.449 |
0.389 |
|
| 2018 |
Burnham SC, Bourgeat P, Budgeon CA, Dore V, Savage G, Laws SM, Salvado O, Maruff P, Martins RN, Ames D, Sperling RA, Masters CL, Rowe CC, Villemagne VL. O4-09-01: COMPARISON OF THE NATURAL HISTORY OF NEOCORTICAL Aβ-AMYLOID, HIPPOCAMPAL VOLUME AND PACC IN SPORADIC AD Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2957 |
0.425 |
|
| 2018 |
Rowe CC, Amadoru S, Dore V, McLean C, Hinton F, Shepherd C, Halliday GM, Leyton CE, Hodges JR, Masters CL, Villemagne VL. O2-06-05: Correlation Of Amyloid Pet Expressed In Centiloid Units With Neuropathological Findings In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2673 |
0.422 |
|
| 2018 |
Harrington KD, Dang C, Lim YY, Ames D, Laws SM, Pietrzak RH, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Villemagne VL, Masters CL, Maruff P. The effect of preclinical Alzheimer's disease on age-related changes in intelligence in cognitively normal older adults Intelligence. 70: 22-29. DOI: 10.1016/J.INTELL.2018.07.004 |
0.316 |
|
| 2017 |
Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Doecke J, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith S, Villemagne VL, Rowe CC, Martins RN, Maruff P, et al. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 45-52. PMID 29560886 DOI: 10.1016/j.bpsc.2016.08.006 |
0.505 |
|
| 2017 |
Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, Salvado O, Bourgeat P, Perez K, Fowler C, Rembach A, Maruff P, Ritchie C, Tanzi R, Masters CL. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study. Alzheimer's & Dementia (New York, N. Y.). 3: 622-635. PMID 29201996 DOI: 10.1016/J.Trci.2017.10.001 |
0.457 |
|
| 2017 |
Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, ... ... Masters CL, et al. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms. Journal of Alzheimer's Disease : Jad. PMID 29171991 DOI: 10.3233/Jad-170128 |
0.622 |
|
| 2017 |
Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports. 7: 14057. PMID 29070909 DOI: 10.1038/S41598-017-14020-9 |
0.669 |
|
| 2017 |
Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain. Nature Reviews. Neurology. PMID 29027541 DOI: 10.1038/Nrneurol.2017.147 |
0.397 |
|
| 2017 |
Wang J, Gu BJ, Masters CL, Wang YJ. A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain. Nature Reviews. Neurology. 13: 612-623. PMID 28960209 DOI: 10.1038/Nrneurol.2017.111 |
0.465 |
|
| 2017 |
Fandos N, Pérez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, Doecke J, Fowler C, Masters CL, Sarasa M. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 179-187. PMID 28948206 DOI: 10.1016/j.dadm.2017.07.004 |
0.313 |
|
| 2017 |
Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, et al. Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline. Brain : a Journal of Neurology. 140: 2112-2119. PMID 28899019 DOI: 10.1093/Brain/Awx137 |
0.454 |
|
| 2017 |
Frost S, Robinson L, Rowe CC, Ames D, Masters CL, Taddei K, Rainey-Smith SR, Martins RN, Kanagasingam Y. Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry. Journal of Ophthalmology. 2017: 7935406. PMID 28894607 DOI: 10.1155/2017/7935406 |
0.482 |
|
| 2017 |
Laws SM, Gaskin S, Woodfield A, Srikanth V, Bruce D, Fraser PE, Porter T, Newsholme P, Wijesekara N, Burnham S, Doré V, Li QX, Maruff P, Masters CL, Rainey-Smith S, et al. Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. Scientific Reports. 7: 9766. PMID 28852028 DOI: 10.1016/J.Jalz.2017.06.2000 |
0.466 |
|
| 2017 |
Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P. Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 156-164. PMID 28761926 DOI: 10.1016/J.Dadm.2017.05.006 |
0.495 |
|
| 2017 |
Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, ... ... Masters CL, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/J.Jalz.2017.06.2268 |
0.539 |
|
| 2017 |
Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Fowler C, Ellis K, Martins RN, Salvado O, Doré V, Villemagne VL, Rowe CC, Laws SM, Masters CL, et al. Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study. International Journal of Geriatric Psychiatry. PMID 28736899 DOI: 10.1002/Gps.4761 |
0.312 |
|
| 2017 |
Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Zhou XF, Martins RN, et al. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF. International Psychogeriatrics. 1-10. PMID 28720165 DOI: 10.1017/S1041610217001284 |
0.462 |
|
| 2017 |
Lu R, Wang J, Tao R, Wang J, Zhu T, Guo W, Sun Y, Li H, Gao Y, Zhang W, Fowler CJ, Li Q, Chen S, Wu Z, Masters CL, et al. Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment. Molecular Psychiatry. PMID 28696436 DOI: 10.1038/Mp.2017.136 |
0.394 |
|
| 2017 |
Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL, Wilkins S, Shackleford DM, Charman SA, Bal W, Zawisza IA, Kurowska E, Gundlach AL, Ma S, Bush AI, et al. The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta Neuropathologica Communications. 5: 53. PMID 28659169 DOI: 10.1186/S40478-017-0456-2 |
0.366 |
|
| 2017 |
Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals. Journal of Alzheimer's Disease : Jad. PMID 28550258 DOI: 10.3233/JAD-170072 |
0.5 |
|
| 2017 |
Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 60-72. PMID 28508031 DOI: 10.1016/J.Dadm.2017.04.003 |
0.643 |
|
| 2017 |
Brown BM, Sohrabi HR, Taddei K, Gardener SL, Rainey-Smith SR, Peiffer JJ, Xiong C, Fagan AM, Benzinger T, Buckles V, Erickson KI, Clarnette R, Shah T, Masters CL, Weiner M, et al. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28501451 DOI: 10.1016/J.Jalz.2017.03.008 |
0.488 |
|
| 2017 |
Rita Cardoso B, Hare DJ, Lind M, McLean CA, Volitakis I, Laws SM, Masters CL, Bush AI, Roberts BR. The APOE ε4 allele is associated with lower selenium levels in the brain: implications in Alzheimer's disease. Acs Chemical Neuroscience. PMID 28453930 DOI: 10.1021/Acschemneuro.7B00014 |
0.708 |
|
| 2017 |
Mukherjee S, Kapp EA, Lothian A, Roberts AM, Vasilev Y, Boughton B, Barnham KJ, Kok WM, Hutton CA, Masters CL, Bush A, Beckman JS, Dey SG, Roberts BR. Characterization and identification of dityrosine cross-linked peptides using tandem mass spectrometry. Analytical Chemistry. PMID 28453255 DOI: 10.1021/Acs.Analchem.7B00941 |
0.733 |
|
| 2017 |
Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, ... ... Masters CL, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Scientific Reports. 7: 1225. PMID 28450713 DOI: 10.1038/S41598-017-01327-W |
0.405 |
|
| 2017 |
Gardener SL, Rainey-Smith SR, Sohrabi HR, Weinborn M, Verdile G, Fernando WM, Lim YY, Harrington K, Burnham S, Taddei K, Masters CL, Macaulay SL, Rowe CC, Ames D, Maruff P, et al. Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner. Journal of Alzheimer's Disease : Jad. PMID 28387666 DOI: 10.3233/Jad-161158 |
0.44 |
|
| 2017 |
Roberts BR, Lind M, Wagen AZ, Rembach A, Frugier T, Li QX, Ryan TM, McLean CA, Doecke JD, Rowe CC, Villemagne VL, Masters CL. Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. Brain : a Journal of Neurology. PMID 28383676 DOI: 10.1093/Brain/Awx057 |
0.687 |
|
| 2017 |
Frost S, Bhuiyan A, Offerman D, Doecke JD, Macaulay SL, Sohrabi HR, Ames D, Masters C, Martins RN, Kanagasingam Y, Aibl Research Group. Modulation of Retinal Arteriolar Central Reflection by APOE genotype. Current Alzheimer Research. PMID 28290247 DOI: 10.2174/1567205014666170309115016 |
0.425 |
|
| 2017 |
Hollands S, Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Harrington K, Porter T, Snyder P, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Rowe CC, ... Masters CL, et al. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28234254 DOI: 10.3233/Jad-161019 |
0.565 |
|
| 2017 |
Cardoso BR, Hare DJ, Bush AI, Li QX, Fowler CJ, Masters CL, Martins RN, Ganio K, Lothian A, Mukherjee S, Kapp EA, Roberts BR. Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL). Journal of Alzheimer's Disease : Jad. PMID 28222503 DOI: 10.3233/Jad-160622 |
0.788 |
|
| 2017 |
Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, ... ... Masters CL, et al. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 56: 1159-1174. PMID 28157104 DOI: 10.3233/Jad-161097 |
0.454 |
|
| 2017 |
Peters KE, Davis WA, Taddei K, Martins RN, Masters CL, Davis TM, Bruce DG. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study. Journal of Alzheimer's Disease : Jad. PMID 28106562 DOI: 10.3233/Jad-161050 |
0.506 |
|
| 2017 |
Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC. Aβ-amyloid and Tau Imaging in Dementia. Seminars in Nuclear Medicine. 47: 75-88. PMID 27987560 DOI: 10.1053/j.semnuclmed.2016.09.006 |
0.395 |
|
| 2017 |
Gardener SL, Rainey-Smith SR, Shen K, Bourgeat P, Taddei K, Ames D, Masters CL, Rowe CC, Salvado O, Martins RN. MEDITERRANEAN DIET ADHERENCE IS ASSOCIATED WITH ATTENUATED CORTICAL THINNING IN AN AUSTRALIAN STUDY OF AGEING Alzheimer's & Dementia. 13: P1567. DOI: 10.1016/J.Jalz.2017.07.724 |
0.391 |
|
| 2017 |
Villemagne VL, Burnham S, Bourgeat P, Dore V, Rainey-Smith SR, Laws SM, Brown BM, Maruff P, Savage G, Ames D, Salvado O, Martins RN, Masters CL, Rowe CC. REFINING THE NATURAL HISTORY OF GLOBAL AND REGIONAL Aβ-AMYLOID DEPOSITION IN SPORADIC ALZHEIMER’S DISEASE Alzheimers & Dementia. 13: 1530. DOI: 10.1016/J.Jalz.2017.07.661 |
0.444 |
|
| 2017 |
Burnham S, Laws SM, Budgeon CA, Dore V, Bourgeat P, Porter T, Salvado O, Masters CL, Rowe CC, Villemagne VL. THE IMPACT OF APOE ε4 CARRIAGE ON Aβ-AMYLOID DEPOSITION IN AIBL Alzheimers & Dementia. 13: 1510. DOI: 10.1016/J.Jalz.2017.07.625 |
0.44 |
|
| 2017 |
Sohrabi HR, Gardener SL, Weinborn M, Shen K, Rainey-Smith SR, Brown BM, Taddei K, Doecke JD, Salvado O, Villemagne VLL, Maruff P, Savage G, Ames D, Masters CL, Rowe CC, et al. Cognitive Super-Aging Versus Typical Aging In Community-Dwelling Older Adults: Longitudinal Trajectories In Global Cortical Thickness Over Six Years Alzheimers & Dementia. 13: 1463. DOI: 10.1016/J.Jalz.2017.07.531 |
0.318 |
|
| 2017 |
Yates PA, Villemagne VLL, Dore V, Burnham S, Martins RN, Rainey-Smith SR, Salvado O, Ames D, Masters CL, Rowe CC. VASCULAR RISK MEASURES AND LONGITUDINAL Aβ ACCUMULATION: RESULTS FROM THE AIBL STUDY OF AGEING Alzheimers & Dementia. 13: 1238. DOI: 10.1016/J.Jalz.2017.07.441 |
0.337 |
|
| 2017 |
McDade E, Wang G, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Hassenstab J, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier KL, Xiong C, Ricardo A, ... ... Masters CL, et al. LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY Alzheimer's & Dementia. 13: P879-P880. DOI: 10.1016/J.Jalz.2017.07.265 |
0.449 |
|
| 2017 |
Doecke JD, Li QX, Fowler C, Collins S, Dore V, Rowe CC, Masters CL, Salvado O, Villemagne VL. CSF P-TAU IS CORRELATED WITH TAU PET, WHILE Aβ PET CORRELATES WITH Aβ1-42 AND THE T-TAU/Aβ1-42 RATIO Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.067 |
0.396 |
|
| 2017 |
Hanseeuw BJ, McDade E, Schultz AP, Martins RN, Schofield PR, Masters CL, Graff-Radford NR, Salloway S, Danek A, Levin J, Buckles V, Goate AM, Benzinger TL, Morris JC, Bateman RJ, et al. GENOTYPIC VARIANCE MAY EXPLAIN THE BALANCE OF EARLY CORTICAL VERSUS STRIATAL AMYLOID DEPOSITION IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P187-P188. DOI: 10.1016/J.Jalz.2017.07.043 |
0.538 |
|
| 2017 |
Villemagne VL, Burnham S, Doecke JD, Bourgeat P, Dore V, Laws SM, Collins S, Li Q, Rainey-Smith SR, Rembach A, Lim YY, Maruff P, Gupta VB, Savage G, Salvado O, ... ... Masters CL, et al. DIAGNOSTIC AND PROGNOSTIC POWER OF FLUID AND NEUROIMAGING MARKERS OF PATHOLOGY AND NEURODEGENERATION: THE ALZHEIMER'S IMAGING, BIOMARKERS, AND LIFESTYLE (AIBL) STUDY OF AGEING EXPERIENCE Alzheimer's & Dementia. 13: P174. DOI: 10.1016/J.Jalz.2017.07.015 |
0.351 |
|
| 2017 |
Doecke JD, Whittle E, Villemagne VL, Masters CL, Roberts BR. [P2-263]: GRAPHICAL NETWORK ANALYSES INFORMS PET Aβ-AMYLOID BIOMARKER DISCOVERY VIA QUANTIFICATION OF INDIVIDUAL PEPTIDE CONNECTIONS Alzheimer's & Dementia. 13: P714-P714. DOI: 10.1016/J.Jalz.2017.06.916 |
0.625 |
|
| 2017 |
Song X, Dhindsa N, Rainey-Smith SR, Guo H, Zeng A, Brown BM, Ames D, Masters CL, Salvado O, Rowe CC, D'Arcy RCN, Martins RN, Rockwood K. Education And Physical Activity In Relation To Frailty And Whole-Brain Structural Health In Alzheimer'S Disease, Mild Cognitive Impairment, And Normal Aging: Results From The Australian Imaging, Biomarkers And Lifestyle Flagship Study Of Ageing (Aibl) Alzheimers & Dementia. 13: 639. DOI: 10.1016/J.Jalz.2017.06.735 |
0.403 |
|
| 2017 |
Maruff P, Barnsby L, Lim YY, Snyder PJ, Harrington KD, Villemagne VL, Rowe CC, Masters CL. [P1-475]: SENSITIVITY OF AN ALZHEIMER's DISEASE COOPERATIVE STUDY: PRECLINICAL ALZHEIMER's COGNITIVE COMPOSITE (PACC) BASED ON COMPUTERIZED TESTS TO AMYLOID LOAD IN PRECLINICAL AD Alzheimer's & Dementia. 13: P471-P471. DOI: 10.1016/J.Jalz.2017.06.491 |
0.482 |
|
| 2017 |
Fazlollahi A, Ayton S, Diouf I, Bourgeat P, Raniga P, Dore V, Ng A, Fripp J, Ames D, Masters CL, Rowe CC, Villemagne VL, Bush AI, Salvado O. QUANTITATIVE SUSCEPTIBILITY MAPPING OF THE HIPPOCAMPUS PREDICTS HIPPOCAMPAL ATROPHY IN Aβ+ ELDERLY CONTROLS AND ALZHEIMER’S DISEASE PATIENTS Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.460 |
0.51 |
|
| 2017 |
Doecke JD, Li Q, Bourgeat P, Fowler C, Collins S, Varghese S, Dore V, Rowe CC, Masters CL, Villemagne VL, Salvado O. Csf Total Tau As A Biomarker For Neuronal Injury In Alzheimer’S Disease: Aligning Rates Of Csf Change With Rates Of Hippocampal And Cortical Gray Matter Atrophy Alzheimers & Dementia. 13: 436. DOI: 10.1016/J.Jalz.2017.06.432 |
0.316 |
|
| 2017 |
Lim YY, Hassenstab J, Cruchaga C, Goate AM, Fagan AM, Benzinger TLS, Maruff P, Masters CL, McDade E, Morris JC, Bateman RJ. Bdnf Val66Met Increases Rate Of Memory Decline, Hippocampal Volume Loss And Tau Accumulation In Autosomal Dominant Alzheimer’S Disease Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.283 |
0.325 |
|
| 2017 |
Cummins TL, Elias A, Hopwood M, Rosenfeld JV, Dore V, Lamb F, Williams R, Guzman R, Salvado O, Masters CL, Villemagne VL, Rowe CC. TAU, Aβ-AMYLOID, AND COGNITIVE FUNCTION FOLLOWING SERVICE-RELATED TRAUMATIC BRAIN INJURY IN VIETNAM WAR VETERANS Alzheimers & Dementia. 13: 101. DOI: 10.1016/J.Jalz.2017.06.2408 |
0.376 |
|
| 2017 |
Yassi N, Hilal S, Lim YY, Salinas S, Kuijf H, Xia Y, Chen C, Salvado O, Rowe CC, Desmond P, Masters CL. Cortical Cerebral Microinfarcts On 3T Mri In Alzheimer’S Disease And Mild Cognitive Impairment Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2124 |
0.319 |
|
| 2017 |
Pedrini S, Gupta VB, Hone E, Doecke JD, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VLL, Ames D, Masters CL, Martins RN. IL-10 AND IL-12/23P40 ARE JOINTLY ASSOCIATED AS PREDICTORS OF Aβ-AMYLOID LOAD IN A BROADER BLOOD-BASED BIOMARKER PANEL Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2002 |
0.462 |
|
| 2017 |
Harrington KD, Schembri A, Lim YY, Ames D, Rainey-Smith SR, Salvado O, Villemagne VLL, Rowe CC, Masters CL, Maruff P. CONSIDERATION OF PRECLINICAL AD FROM THE PERSPECTIVE OF NORMAL AGING: AMYLOID-β RELATED CHANGES IN FLUID AND CRYSTALLIZED INTELLIGENCE IN A ROBUST SAMPLE OF HEALTHY OLDER ADULTS Alzheimers & Dementia. 13: 1150. DOI: 10.1016/J.Jalz.2017.06.1680 |
0.37 |
|
| 2017 |
Hearn N, Dore V, Fripp J, Grothe MJ, Teipel SJ, Masters CL, Rowe CC, Coulson E, Villemagne VLL. Global tau burden correlates with basal forebrain atrophy in healthy aging subjects Alzheimers & Dementia. 13: 1089. DOI: 10.1016/J.Jalz.2017.06.1565 |
0.624 |
|
| 2017 |
Ashton NJ, Narvardo-Holgado AJ, Lynham S, Ward M, Gupta VB, Chatterjee P, Goozee K, Hone E, Pedrini S, Bush AI, Rowe CC, Villemagne VLL, Ames D, Masters CL, Aarsland D, et al. A mass spectrometry-based discovery and replication of a multi-analyte classifier for neocortical amyloid pathology Alzheimers & Dementia. 13: 1033. DOI: 10.1016/J.Jalz.2017.06.1456 |
0.58 |
|
| 2017 |
Hone E, Pedrini S, Gupta VB, Russell A, Laws SM, Villemagne VLL, Rowe CC, Ames D, Masters CL, Martins RN. The Influence Of Low-Density Lipoproteins On Neocortical Amyloid Load In The Australian Imaging Biomarker And Lifestyle Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1437 |
0.319 |
|
| 2017 |
Rowe CC, Dore V, Bourgeat P, Williams R, Ames D, Salvado O, Masters CL, Villemagne VLL. LONGITUDINAL ASSESSMENT OF Aβ ACCUMULATION WITH FLUTEMETAMOL Alzheimers & Dementia. 13: 778. DOI: 10.1016/J.Jalz.2017.06.1044 |
0.39 |
|
| 2017 |
Villemagne VLL, Velakoulis D, Dore V, Bozinovski S, Masters CL, Rowe CC, Waterfang M. TAU AND Aβ-AMYLOID IMAGING IN NIEMANN-PICK TYPE C Alzheimers & Dementia. 13: 756. DOI: 10.1016/J.Jalz.2017.06.1003 |
0.406 |
|
| 2017 |
Taswell C, Donohue CL, Mastwyk M, Louey A, Giummarra J, Darby D, Villemagne V, Masters C, Rowe C. Safety of Disclosing Amyloid Imaging Results to MCI and AD Patients The American Journal of Geriatric Psychiatry. 25: S129. DOI: 10.1016/J.Jagp.2017.01.147 |
0.394 |
|
| 2016 |
Sabbagh MN, Schäuble B, Anand K, Richards D, Murayama S, Akatsu H, Takao M, Rowe CC, Masters CL, Barthel H, Gertz HJ, Peters O, Rasgon N, Jovalekic A, Sabri O, et al. Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27983552 DOI: 10.3233/Jad-160821 |
0.36 |
|
| 2016 |
Roberts BR, Doecke JD, Rembach A, Yévenes LF, Fowler CJ, McLean CA, Lind M, Volitakis I, Masters CL, Bush AI, Hare DJ. Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid. Acta Neuropathologica Communications. 4: 119. PMID 27842602 DOI: 10.1186/S40478-016-0390-8 |
0.702 |
|
| 2016 |
Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, ... ... Masters CL, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0 |
0.43 |
|
| 2016 |
Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Martins RN, Salvado O, Dore V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Maruff P, Pietrzak RH, et al. β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27742526 DOI: 10.1016/J.Jagp.2016.08.007 |
0.447 |
|
| 2016 |
Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Corrigendum: Corrigendum to 'Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment'. Age and Ageing. 45: 742. PMID 27646269 DOI: 10.1093/Ageing/Afw117 |
0.322 |
|
| 2016 |
Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Bourgeat P, Martins RN, Salvado O, Rowe CC, Masters CL, Maruff P. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia. Journal of Molecular Neuroscience : Mn. PMID 27586003 DOI: 10.1007/s12031-016-0822-8 |
0.485 |
|
| 2016 |
Cerin E, Rainey-Smith SR, Ames D, Lautenschlager NT, Macaulay SL, Fowler C, Robertson JS, Rowe CC, Maruff P, Martins RN, Masters CL, Ellis KA. Associations of neighborhood environment with brain imaging outcomes in the AIBL cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27546307 DOI: 10.1016/j.jalz.2016.06.2364 |
0.339 |
|
| 2016 |
Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, et al. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up. Neurology. PMID 27534714 DOI: 10.1212/Wnl.0000000000003094 |
0.658 |
|
| 2016 |
Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 27521573 DOI: 10.1093/Brain/Aww200 |
0.356 |
|
| 2016 |
Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, Sperling R, Amariglio R. A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease. Journal of Molecular Neuroscience : Mn. PMID 27514526 DOI: 10.1007/S12031-016-0810-Z |
0.311 |
|
| 2016 |
Heffernan AL, Chidgey C, Peng P, Masters CL, Roberts BR. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts. Journal of Molecular Neuroscience : Mn. PMID 27498201 DOI: 10.1007/s12031-016-0804-x |
0.638 |
|
| 2016 |
Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. The Lancet. Neurology. PMID 27450471 DOI: 10.1016/S1474-4422(16)30125-9 |
0.493 |
|
| 2016 |
Gu BJ, Huang X, Ou A, Rembach A, Fowler C, Avula PK, Horton A, Doecke JD, Villemagne VL, Macaulay SL, Maruff P, Fletcher EL, Guymer R, Wiley JS, Masters CL, et al. Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's disease. Acta Neuropathologica. PMID 27411339 DOI: 10.1007/S00401-016-1596-3 |
0.404 |
|
| 2016 |
Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Scientific Reports. 6: 29078. PMID 27381087 DOI: 10.1038/Srep29078 |
0.45 |
|
| 2016 |
Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, ... ... Masters CL, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain : a Journal of Neurology. PMID 27357349 DOI: 10.1093/Brain/Aww159 |
0.346 |
|
| 2016 |
Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y, Group AT. Alzheimer`s disease and the early signs of age-related macular degeneration. Current Alzheimer Research. PMID 27335042 DOI: 10.2174/1567205013666160603003800 |
0.502 |
|
| 2016 |
Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN, et al. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 18-26. PMID 27239546 DOI: 10.1016/J.Dadm.2015.12.001 |
0.645 |
|
| 2016 |
Lim YY, Snyder PJ, Pietrzak RH, Ukiqi A, Villemagne VL, Ames D, Salvado O, Bourgeat P, Martins RN, Masters CL, Rowe CC, Maruff P. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score. Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 19-26. PMID 27239532 DOI: 10.1016/j.dadm.2015.11.003 |
0.463 |
|
| 2016 |
Hare DJ, Raven EP, Roberts BR, Bogeski M, Portbury SD, McLean CA, Masters CL, Connor JR, Bush AI, Crouch PJ, Doble PA. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and grey matter iron distribution in Alzheimer's disease frontal cortex. Neuroimage. PMID 27233149 DOI: 10.1016/J.Neuroimage.2016.05.057 |
0.648 |
|
| 2016 |
Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, Rainey-Smith S, Martins RN, Salvado O, Villemagne VL, Rowe CC, Masters CL, Maruff P. Amyloid burden and incident depressive symptoms in cognitively normal older adults. International Journal of Geriatric Psychiatry. PMID 27114112 DOI: 10.1002/gps.4489 |
0.449 |
|
| 2016 |
Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN, et al. The Relationship between Sleep Quality and Brain Amyloid Burden. Sleep. PMID 27091528 |
0.385 |
|
| 2016 |
Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease. Neurology. PMID 27029632 DOI: 10.1212/Wnl.0000000000002604 |
0.541 |
|
| 2016 |
Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Masters CL, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647 |
0.494 |
|
| 2016 |
Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, ... ... Masters CL, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0152082. PMID 27010959 DOI: 10.1371/Journal.Pone.0152082 |
0.322 |
|
| 2016 |
François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Lance Macaulay S, Hill AF, Leifert WR, The Australian Imaging Biomarkers And Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease. Current Alzheimer Research. PMID 26975368 DOI: 10.2174/1567205013666160315112151 |
0.509 |
|
| 2016 |
Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, Rainey-Smith S, Lautenschlager N, Rowe CC, Savage G, Villemagne VL, Ellis KA. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26852195 DOI: 10.1016/j.jalz.2015.12.013 |
0.417 |
|
| 2016 |
Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T, Masters C, Snowden SG, Wenk MR, Bateman RJ, et al. Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study. Journal of Alzheimer's Disease : Jad. PMID 26836186 DOI: 10.3233/Jad-150948 |
0.449 |
|
| 2016 |
Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN. The relationship between sleep quality and brain amyloid burden Sleep. 39: 1063-1068. DOI: 10.5665/sleep.5756 |
0.361 |
|
| 2016 |
Ritchie CW, Webster S, Cummings JL, Masters CL, Ruffles V, Seckl J, Walker BR. P4-388: XANAMEMTM
: A Novel 11B-HSD1 Inhibitor with Potential to Provide Durable Symptomatic and Disease Modifying Benefits in Alzheimer’S Disease Alzheimer's & Dementia. 12: P1186-P1186. DOI: 10.1016/J.Jalz.2016.07.133 |
0.321 |
|
| 2016 |
Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Pejoska S, Salvado O, Bourgeat P, Perez K, Fowler C, Rembach A, Maruff P, Tanzi R, Ritchie CW, Masters CL. P1-042: An Exploratory Molecular Imaging Study Targeting Aβ with A Novel 8-OH Quinoline in Alzheimer’s Disease (The PBT2-204 Imagine Study) Alzheimer's & Dementia. 12: P417-P417. DOI: 10.1016/J.Jalz.2016.06.789 |
0.448 |
|
| 2016 |
Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith SR, Villemagne VL, Rowe CC, Martins RN, Maruff P. Plasma Cortisol, Amyloid-B, And Cognitive Decline In Preclinical Alzheimer’S Disease Alzheimers & Dementia. 12: 960. DOI: 10.1016/J.Jalz.2016.06.1972 |
0.404 |
|
| 2016 |
Gu BJ, Ou A, Huang X, Rembach A, Fowler C, Doecke JD, Villemagne VL, Maruff P, Macaulay SL, Guymer R, Wiley JS, Masters CL. Altered Peripheral Monocyte Innate Phagocytosis In Alzheimer’S Disease Alzheimers & Dementia. 12: 866. DOI: 10.1016/J.Jalz.2016.06.1781 |
0.313 |
|
| 2016 |
Yates PA, Rowe CC, Ames D, Masters CL, Martins RN, Burnham S, Maruff P, Ellis KA, Villemagne VL. ANTIHYPERTENSIVE TREATMENT AND LONGITUDINAL Aβ MEASURES: RESULTS FROM THE AIBL STUDY OF AGEING Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1049 |
0.342 |
|
| 2016 |
Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 3: 18-26. DOI: 10.1016/j.dadm.2015.12.001 |
0.602 |
|
| 2015 |
Kerestes R, Phal PM, Steward C, Moffat BA, Salinas S, Cox KL, Ellis KA, Cyarto EV, Ames D, Martins RN, Masters CL, Rowe CC, Sharman MJ, Salvado O, Szoeke C, et al. Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease. Bjpsych Open. 1: 139-148. PMID 27703739 DOI: 10.1192/bjpo.bp.115.001339 |
0.382 |
|
| 2015 |
Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer's disease. Nature Reviews. Disease Primers. 1: 15056. PMID 27188934 DOI: 10.1038/nrdp.2015.56 |
0.347 |
|
| 2015 |
Gunn AP, Wong BX, Johanssen T, Griffith JC, Masters CL, Bush AI, Barnham KJ, Duce JA, Cherny RA. Amyloid-Beta Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization and Calcium-Influx in Neurons. The Journal of Biological Chemistry. PMID 26697885 DOI: 10.1074/Jbc.M115.655183 |
0.517 |
|
| 2015 |
Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, ... ... Masters CL, et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. Journal of Alzheimer's Disease : Jad. PMID 26639956 DOI: 10.3233/Jad-150446 |
0.556 |
|
| 2015 |
Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, ... ... Masters CL, et al. Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology. Alzheimer's Research & Therapy. 7: 71. PMID 26581886 DOI: 10.1186/s13195-015-0157-7 |
0.434 |
|
| 2015 |
Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment. Age and Ageing. 44: 1012-9. PMID 26452663 DOI: 10.1093/Ageing/Afv136 |
0.326 |
|
| 2015 |
Thai C, Lim YY, Villemagne VL, Laws SM, Ames D, Ellis KA, Rainey-Smith SR, Martins RN, Masters CL, Rowe CC, Maruff P. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months. Plos One. 10: e0139082. PMID 26430784 DOI: 10.1371/journal.pone.0139082 |
0.398 |
|
| 2015 |
Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. Journal of Alzheimer's Disease : Jad. 46: 1079-89. PMID 26402634 DOI: 10.3233/JAD-143015 |
0.467 |
|
| 2015 |
Leifert WR, Nguyen T, Rembach A, Martins R, Rainey-Smith S, Masters CL, Ames D, Rowe CC, Macaulay SL, François M, Fenech MF. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk. Journal of Alzheimer's Disease : Jad. 48: 443-52. PMID 26402008 DOI: 10.3233/Jad-150330 |
0.486 |
|
| 2015 |
Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, ... ... Masters CL, et al. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Alzheimer's Disease : Jad. 48: 175-87. PMID 26401938 DOI: 10.3233/JAD-150247 |
0.514 |
|
| 2015 |
Banik A, Brown RE, Bamburg J, Lahiri DK, Khurana D, Friedland RP, Chen W, Ding Y, Mudher A, Padjen AL, Mukaetova-Ladinska E, Ihara M, Srivastava S, Padma Srivastava MV, Masters CL, et al. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1. Journal of Alzheimer's Disease : Jad. 47: 815-43. PMID 26401762 DOI: 10.3233/Jad-150136 |
0.303 |
|
| 2015 |
Li X, Lei P, Tuo Q, Ayton S, Li QX, Moon S, Volitakis I, Liu R, Masters CL, Finkelstein DI, Bush AI. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 862-73. PMID 26260389 DOI: 10.1007/S13311-015-0378-2 |
0.602 |
|
| 2015 |
Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... ... Masters CL, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903 |
0.432 |
|
| 2015 |
Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK. Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status. Neuropsychologia. 75: 411-419. PMID 26102189 DOI: 10.1016/J.Neuropsychologia.2015.06.008 |
0.488 |
|
| 2015 |
Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, et al. Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimer's Research & Therapy. 7: 16. PMID 25859282 DOI: 10.1186/S13195-015-0105-6 |
0.63 |
|
| 2015 |
Ryan TM, Roberts BR, McColl G, Hare DJ, Doble PA, Li QX, Lind M, Roberts AM, Mertens HD, Kirby N, Pham CL, Hinds MG, Adlard PA, Barnham KJ, Curtain CC, ... Masters CL, et al. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 2871-84. PMID 25698727 DOI: 10.1523/Jneurosci.2912-14.2015 |
0.668 |
|
| 2015 |
Ryan TM, Kirby N, Mertens HD, Roberts B, Barnham KJ, Cappai R, Pham Cle L, Masters CL, Curtain CC. Small angle X-ray scattering analysis of Cu(2+)-induced oligomers of the Alzheimer's amyloid β peptide. Metallomics : Integrated Biometal Science. 7: 536-43. PMID 25687761 DOI: 10.1039/c4mt00323c |
0.623 |
|
| 2015 |
Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM, et al. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. Neuropsychology. 29: 571-81. PMID 25664464 DOI: 10.1037/Neu0000156 |
0.467 |
|
| 2015 |
Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. Jama Psychiatry. 72: 284-91. PMID 25629787 DOI: 10.1001/jamapsychiatry.2014.2476 |
0.488 |
|
| 2015 |
Rembach A, Stingo FC, Peterson C, Vannucci M, Do KA, Wilson WJ, Macaulay SL, Ryan TM, Martins RN, Ames D, Masters CL, Doecke JD. Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 917-25. PMID 25613103 DOI: 10.3233/Jad-141497 |
0.536 |
|
| 2015 |
Hare DJ, Doecke JD, Faux NG, Rembach A, Volitakis I, Fowler CJ, Grimm R, Doble PA, Cherny RA, Masters CL, Bush AI, Roberts BR. Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation. Acs Chemical Neuroscience. 6: 398-402. PMID 25588002 DOI: 10.1021/Cn5003557 |
0.674 |
|
| 2015 |
Pietrzak RH, Lim YY, Ames D, Harrington K, Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne VL, Rowe CC, Maruff P. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Neurobiology of Aging. 36: 1231-8. PMID 25585532 DOI: 10.1016/j.neurobiolaging.2014.12.015 |
0.363 |
|
| 2015 |
Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease. Neurobiology of Aging. 36: 1239-44. PMID 25559335 DOI: 10.1016/j.neurobiolaging.2014.12.008 |
0.494 |
|
| 2015 |
Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. The Lancet. Neurology. 14: 114-24. PMID 25496902 DOI: 10.1016/S1474-4422(14)70252-2 |
0.434 |
|
| 2015 |
Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 30: 49-58. PMID 25467942 DOI: 10.1093/arclin/acu068 |
0.486 |
|
| 2015 |
Murphy M, Wilson YM, Vargas E, Munro KM, Smith B, Huang A, Li QX, Xiao J, Masters CL, Reid CA, Barrett GL. Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer's disease. Neurobiology of Aging. 36: 740-52. PMID 25443284 DOI: 10.1016/j.neurobiolaging.2014.09.014 |
0.309 |
|
| 2015 |
Roberts BR, Hare DJ, McLean CA, Conquest A, Lind M, Li QX, Bush AI, Masters CL, Morganti-Kossmann MC, Frugier T. Traumatic brain injury induces elevation of Co in the human brain. Metallomics : Integrated Biometal Science. 7: 66-70. PMID 25424382 DOI: 10.1039/C4Mt00258J |
0.607 |
|
| 2015 |
Watt AD, Perez KA, Ang CS, O'Donnell P, Rembach A, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Faux NG, Masters CL, Villemagne VL, Barnham KJ. Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 1131-43. PMID 25408207 DOI: 10.3233/JAD-142286 |
0.348 |
|
| 2015 |
Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, Masters CL, Ames D, Ellis K, Rowe CC, Salvado O, Fripp J. Comparison of MR-less PiB SUVR quantification methods. Neurobiology of Aging. 36: S159-66. PMID 25257985 DOI: 10.1016/J.Neurobiolaging.2014.04.033 |
0.487 |
|
| 2015 |
Robb E, Perez K, Hung LW, Masters CL, Barnham KJ, Cherny RA, Bush AI, Adlard PA, Finkelstein DI. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer. Journal of Alzheimer's Disease : Jad. 44: 69-78. PMID 25182735 DOI: 10.3233/Jad-132024 |
0.522 |
|
| 2015 |
Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. Journal of Alzheimer's Disease : Jad. 43: 677-86. PMID 25114076 DOI: 10.3233/JAD-140678 |
0.453 |
|
| 2015 |
Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, et al. Dietary patterns and cognitive decline in an Australian study of ageing. Molecular Psychiatry. 20: 860-6. PMID 25070537 DOI: 10.1038/Mp.2014.79 |
0.344 |
|
| 2015 |
Ong KT, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau AM, Stephens AW, Seibyl J, Dinkelborg LM, Reininger CB, Putz B, Rohde B, Masters CL, Rowe CC. Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 431-6. PMID 24970906 DOI: 10.1136/jnnp-2014-308094 |
0.355 |
|
| 2015 |
Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study Journal of Alzheimer's Disease. 46: 1079-1089. DOI: 10.3233/JAD-143015 |
0.425 |
|
| 2015 |
Ryan TM, Roberts BR, McColl G, Hare DJ, Hinds MG, Barnham KJ, Curtain CC, Masters CL. F5-02-03: Targeting Aβ oligomer formation in Alzheimer's disease: Challenges and alternatives to oligomer-specific therapeutic avenues Alzheimer's & Dementia. 11: P305-P305. DOI: 10.1016/j.jalz.2015.07.429 |
0.639 |
|
| 2015 |
Li X, Lei P, Tuo Q, Ayton S, Li QX, Moon S, Volitakis I, Liu R, Masters CL, Finkelstein DI, Bush AI. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau Neurotherapeutics. DOI: 10.1007/s13311-015-0378-2 |
0.473 |
|
| 2014 |
Johnson P, Vandewater L, Wilson W, Maruff P, Savage G, Graham P, Macaulay LS, Ellis KA, Szoeke C, Martins RN, Rowe CC, Masters CL, Ames D, Zhang P. Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. Bmc Bioinformatics. 15: S11. PMID 25521394 DOI: 10.1186/1471-2105-15-S16-S11 |
0.513 |
|
| 2014 |
Villemagne VL, Masters CL. Alzheimer disease: the landscape of ageing--insights from AD imaging markers. Nature Reviews. Neurology. 10: 678-9. PMID 25366111 DOI: 10.1038/Nrneurol.2014.214 |
0.425 |
|
| 2014 |
Zwan MD, Okamura N, Fodero-Tavoletti MT, Furumoto S, Masters CL, Rowe CC, Villemagne VL. Voyage au bout de la nuit: Aβ and tau imaging in dementias. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 58: 398-412. PMID 25358680 |
0.391 |
|
| 2014 |
Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Molecular Psychiatry. PMID 25349172 DOI: 10.1038/mp.2014.127 |
0.423 |
|
| 2014 |
Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease. Molecular Psychiatry. PMID 25288138 DOI: 10.1038/mp.2014.123 |
0.507 |
|
| 2014 |
Caine JM, Churches Q, Waddington L, Nigro J, Breheney K, Masters CL, Nuttall SD, Streltsov VA. Design of non-aggregating variants of Aβ peptide. Biochemical and Biophysical Research Communications. 453: 449-54. PMID 25281534 DOI: 10.1016/J.Bbrc.2014.09.102 |
0.437 |
|
| 2014 |
Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Current Neurology and Neuroscience Reports. 14: 499. PMID 25217249 DOI: 10.1007/S11910-014-0499-8 |
0.395 |
|
| 2014 |
Brown BM, Bourgeat P, Peiffer JJ, Burnham S, Laws SM, Rainey-Smith SR, Bartrés-Faz D, Villemagne VL, Taddei K, Rembach A, Bush A, Ellis KA, Macaulay SL, Rowe CC, Ames D, ... Masters CL, et al. Influence of BDNF Val66Met on the relationship between physical activity and brain volume. Neurology. 83: 1345-52. PMID 25186863 DOI: 10.1212/Wnl.0000000000000867 |
0.521 |
|
| 2014 |
Adlard PA, Li QX, McLean C, Masters CL, Bush AI, Fodero-Tavoletti M, Villemagne V, Barnham KJ. β-amyloid in biological samples: not all Aβ detection methods are created equal. Frontiers in Aging Neuroscience. 6: 203. PMID 25165449 DOI: 10.3389/Fnagi.2014.00203 |
0.551 |
|
| 2014 |
Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Masters CL, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/Jamaneurol.2014.1654 |
0.535 |
|
| 2014 |
Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Villemagne VL, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Szoeke C, Masters CL, Rainey-Smith SR, Rembach A, Savage G, et al. Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults. International Psychogeriatrics / Ipa. 26: 1737-46. PMID 24969443 DOI: 10.1017/S1041610214001136 |
0.546 |
|
| 2014 |
Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/Wnl.0000000000000596 |
0.444 |
|
| 2014 |
Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation. Journal of Neuroimmunology. 273: 65-71. PMID 24907904 DOI: 10.1016/J.Jneuroim.2014.05.005 |
0.63 |
|
| 2014 |
Roberts BR, Lim NK, McAllum EJ, Donnelly PS, Hare DJ, Doble PA, Turner BJ, Price KA, Lim SC, Paterson BM, Hickey JL, Rhoads TW, Williams JR, Kanninen KM, Hung LW, ... ... Masters CL, et al. Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8021-31. PMID 24899723 DOI: 10.1523/Jneurosci.4196-13.2014 |
0.604 |
|
| 2014 |
Rembach A, Hare DJ, Doecke JD, Burnham SC, Volitakis I, Fowler CJ, Cherny RA, McLean C, Grimm R, Martins R, Ames D, Masters CL, Bush AI, Roberts BR. Decreased serum zinc is an effect of ageing and not Alzheimer's disease. Metallomics : Integrated Biometal Science. 6: 1216-9. PMID 24676028 DOI: 10.1039/C4Mt00060A |
0.751 |
|
| 2014 |
Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O, Ellis KA, Martins RN, Masters CL, Ames D, Villemagne VL, Rowe CC. Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology. 82: 1266-73. PMID 24623839 DOI: 10.1212/Wnl.0000000000000285 |
0.546 |
|
| 2014 |
Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/Scitranslmed.3007901 |
0.586 |
|
| 2014 |
Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 743-751.e1. PMID 24589436 DOI: 10.1016/j.jalz.2013.11.005 |
0.495 |
|
| 2014 |
Fodero-Tavoletti MT, Furumoto S, Taylor L, McLean CA, Mulligan RS, Birchall I, Harada R, Masters CL, Yanai K, Kudo Y, Rowe CC, Okamura N, Villemagne VL. Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies. Alzheimer's Research & Therapy. 6: 11. PMID 24572336 DOI: 10.1186/Alzrt240 |
0.339 |
|
| 2014 |
Pietrzak RH, Scott JC, Neumeister A, Lim YY, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study. The British Journal of Psychiatry : the Journal of Mental Science. 204: 400-1. PMID 24526746 DOI: 10.1192/Bjp.Bp.113.134239 |
0.481 |
|
| 2014 |
Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 41: 816-26. PMID 24514874 DOI: 10.1007/S00259-013-2681-7 |
0.447 |
|
| 2014 |
Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing. Journal of Alzheimer's Disease : Jad. 40: 551-61. PMID 24496075 DOI: 10.3233/Jad-131820 |
0.329 |
|
| 2014 |
Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K, Bourgeat P, Bush AI, Martins RN, Masters CL, Rowe CC, Maruff P. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. Plos One. 9: e86498. PMID 24475133 DOI: 10.1371/Journal.Pone.0086498 |
0.633 |
|
| 2014 |
Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Frontiers in Neurology. 4: 205. PMID 24432010 DOI: 10.3389/Fneur.2013.00205 |
0.376 |
|
| 2014 |
Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, Bush AI. An anemia of Alzheimer's disease. Molecular Psychiatry. 19: 1227-34. PMID 24419041 DOI: 10.1038/Mp.2013.178 |
0.632 |
|
| 2014 |
Coleman BM, Harrison CF, Guo B, Masters CL, Barnham KJ, Lawson VA, Hill AF. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. Journal of Virology. 88: 2690-703. PMID 24352465 DOI: 10.1128/Jvi.02720-13 |
0.337 |
|
| 2014 |
Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. Journal of Alzheimer's Disease : Jad. 40: 95-104. PMID 24334723 DOI: 10.3233/Jad-131802 |
0.648 |
|
| 2014 |
Ellis KA, Szoeke C, Bush AI, Darby D, Graham PL, Lautenschlager NT, Macaulay SL, Martins RN, Maruff P, Masters CL, McBride SJ, Pike KE, Rainey-Smith SR, Rembach A, Robertson J, et al. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). International Psychogeriatrics / Ipa. 26: 543-54. PMID 24252258 DOI: 10.1017/S1041610213001956 |
0.595 |
|
| 2014 |
Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, Martins RN, Masters CL, Rowe CC, Szoeke C, Watters DA. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. Journal of Alzheimer's Disease : Jad. 39: 661-8. PMID 24246419 DOI: 10.3233/Jad-131265 |
0.562 |
|
| 2014 |
Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain : a Journal of Neurology. 137: 221-31. PMID 24176981 DOI: 10.1093/brain/awt286 |
0.477 |
|
| 2014 |
Pham CL, Kirby N, Wood K, Ryan T, Roberts B, Sokolova A, Barnham KJ, Masters CL, Knott RB, Cappai R, Curtain CC, Rekas A. Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study. Proteins. 82: 10-21. PMID 23733394 DOI: 10.1002/prot.24332 |
0.579 |
|
| 2014 |
Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, ... ... Masters CL, et al. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Molecular Psychiatry. 19: 519-26. PMID 23628985 DOI: 10.1038/Mp.2013.40 |
0.634 |
|
| 2014 |
Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, ... ... Masters CL, et al. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 53-61. PMID 23491263 DOI: 10.1016/J.Jalz.2012.12.006 |
0.754 |
|
| 2014 |
Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, Taddei K, Villemagne VL, et al. Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. Molecular Psychiatry. 19: 69-75. PMID 23089633 DOI: 10.1038/Mp.2012.147 |
0.65 |
|
| 2014 |
Hare DJ, George JL, Bray L, Volitakis I, Vais A, Ryan TM, Cherny RA, Bush AI, Masters CL, Adlard PA, Doble PA, Finkelstein DI. Errratum: The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue (Journal of Analytical Atomic Spectrometry (2013) DOI: 10.1039/C3JA50281C) Journal of Analytical Atomic Spectrometry. 29: 1726. DOI: 10.1039/C4JA90043J |
0.311 |
|
| 2014 |
Hare DJ, Lei P, Ayton S, Roberts BR, Grimm R, George JL, Bishop DP, Beavis AD, Donovan SJ, McColl G, Volitakis I, Masters CL, Adlard PA, Cherny RA, Bush AI, et al. An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta Chemical Science. 5: 2160-2169. DOI: 10.1039/C3Sc53461H |
0.615 |
|
| 2014 |
Hare DJ, George JL, Bray L, Volitakis I, Vais A, Ryan TM, Cherny RA, Bush AI, Masters CL, Adlard PA, Doble PA, Finkelstein DI. The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue Journal of Analytical Atomic Spectrometry. 29: 565-570. DOI: 10.1039/C3Ja50281C |
0.341 |
|
| 2014 |
Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Comparison Of Three Normative Data Correction Approaches: A Cross-Sectional Evaluation In The Aibl Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.07.064 |
0.361 |
|
| 2014 |
Burnham S, Raghavan N, Wilson B, Baker D, Ropacki MT, Novak G, Ames D, Ellis KA, Martins R, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Twyman R, et al. Novel Statistically-Derived Composite Measures For Assessing The Efficacy Of Disease-Modifying Therapies In Prodromal Ad Trials: An Aipl Study Alzheimers & Dementia. 10: 567. DOI: 10.1016/J.Jalz.2014.05.927 |
0.479 |
|
| 2014 |
Szoeke C, Robertson JS, Lehert P, Rowe CC, Masters CL, Ames D, Dennerstein L, Desmond P. A Simple Test Of Episodic Memory Predicts Conversion To Disease (Mci/Ad) A Decade Later: Data From The Women’S Healthy Ageing Project (Whap) Alzheimers & Dementia. 10: 435. DOI: 10.1016/J.Jalz.2014.05.576 |
0.425 |
|
| 2014 |
Lim YY, Villemagne VL, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Martins RN, Masters CL, Rowe CC, Maruff P. Utility Of The Cognigram Brief Battery In Assessing Cognitive Changes Associated With Ab And Apoe Genotype In Preclinical Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.563 |
0.42 |
|
| 2014 |
Maruff PT, Hollands S, Lim YY, Buckley R, Villemange V, Pietrzak R, Snyder PJ, Ames D, Ellis KA, Harrington K, Martins RN, Masters CL, Rowe CC. Healthy Adults With Amyloid-Related Memory Decline Report No Concomitant Decline In Subjective Reports Of Their Memory Impairment Alzheimers & Dementia. 10: 380. DOI: 10.1016/J.Jalz.2014.05.450 |
0.303 |
|
| 2014 |
Buckley R, Saling M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay L, Martins R, Szoeke C, Masters C, Rainey-Smith SR, Rembach A, Savage G, Ellis KA. P4-164: QUALITATIVE THEMATIC ANALYSIS OF SUBJECTIVE MEMORY COMPLAINTS IN THE HEALTHY ELDERLY AND INDIVIDUALS WITH MCI Alzheimer's & Dementia. 10: P849-P850. DOI: 10.1016/J.Jalz.2014.05.1681 |
0.403 |
|
| 2014 |
McCluskey GE, Yates PA, Rowe CC, Ames D, Masters CL, Dennerstein L, Desmond P, Szoeke C. Reported episodes of confusion in healthy participants have a relationship with cerebral amyloid load: Data from the women's healthy ageing project Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1601 |
0.322 |
|
| 2014 |
Szoeke C, Yates PA, Masters CL, Ames D, Dennerstein L, Rowe CC. P4-082: PARTICIPANTS WHO REFUSE PET SCAN HAD SIGNIFICANTLY LOWER EPISODIC MEMORY THAN THOSE WHO CONSENTED TO SCAN: DATA FROM THE WOMEN's HEALTHY AGEING PROJECT Alzheimer's & Dementia. 10: P813-P813. DOI: 10.1016/J.Jalz.2014.05.1597 |
0.428 |
|
| 2014 |
Gupta VB, Pedrini S, Hone E, Deocke J, Obryant S, Masters CL, Martins R. Peripheral Biomarkers Differentiate Between Transitional And Non-Transitional Clinical Groups In The Longitudinal Australian Imaging Biomarkers And Lifestyle Study Of Aging Alzheimers & Dementia. 10: 807. DOI: 10.1016/J.Jalz.2014.05.1582 |
0.398 |
|
| 2014 |
Szoeke C, Lehert P, Yates PA, Villemagne VL, Masters CL, Ames D, Dennerstein L, Desmond P, Rowe CC. Participants With A Positive Amyloid Scan In The Women’S Healthy Ageing Project Had Significantly Worse Episodic Memory Than Those With A Negative Scan Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1571 |
0.304 |
|
| 2014 |
Fowler CJ, Yevenes LF, Rembach A, Faux NG, Trounson B, Pertile K, Rumble R, Ellis KA, Ames D, Bush AI, Martins R, Masters CL. P3-114: ELEVATED BLOOD HDL AND HDL-ASSOCIATED LIPOPROTEINS IN HEALTHY CONTROLS WHO RAPIDLY CONVERT TO ALZHEIMER'S DISEASE IN THE AIBL COHORT Alzheimer's & Dementia. 10: P670-P670. DOI: 10.1016/J.Jalz.2014.05.1203 |
0.565 |
|
| 2014 |
Wilson AC, Garin S, Porter TLS, Verdile G, Groth DM, Villemagne VL, Ames D, Bush AI, Ellis KA, Macaulay L, Masters CL, Rainey-Smith SR, Rembach A, Rowe C, Taddei K, et al. Genetic Analysis Of The Steroidogenesis Pathway: Associations With Alzheimer'S Disease Risk And Related Phenotypes Alzheimers & Dementia. 10: 667. DOI: 10.1016/J.Jalz.2014.05.1195 |
0.549 |
|
| 2014 |
Laws SM, Porter T, Creegan R, Lim WLF, Verdile G, Groth DM, Villemagne V, Wilson AC, Ames D, Bush AI, Ellis KA, Macaulay L, Masters CL, Rainey-Smith SL, Rembach A, et al. Genetic Variation Within Genes Of The Sphingolipid Metabolism Pathway And Their Association With Alzheimer'S Disease Risk And Related Phenotypes Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1110 |
0.5 |
|
| 2014 |
Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau A, Stephens A, Seibyl J, Dinkelborg L, Reininger C, Putz B, Rohde B, Masters CL, Rowe CC. DETECTION OF PRODROMAL ALZHEIMER'S DISEASE WITH 18F-FLORBETABEN Aβ IMAGING: A PROSPECTIVE OUTCOME STUDY Alzheimers & Dementia. 10: 42. DOI: 10.1016/J.Jalz.2014.05.080 |
0.41 |
|
| 2014 |
Yates P, Villemagne VL, Bourgeat P, Ellis KA, Martins R, Szoeke C, Desmond P, Masters CL, Ames D, Rowe CC. Brain Beta-Amyloid, Vascular Factors, And Cognition: 54-Month Followup Results From The Aipl Study Alzheimers & Dementia. 10: 17. DOI: 10.1016/J.Jalz.2014.05.026 |
0.494 |
|
| 2014 |
Yates P, Villemagne VL, Robertson J, Dennerstein L, Li C, Desmond P, Masters CL, Szoeke C, Rowe CC. Evidence Of Amyloid On Florbetaben-Pet Is Associated With Reduced Episodic Memory 10 Years Prior: Results From The Women’S Healthy Ageing Project Alzheimers & Dementia. 10: 16. DOI: 10.1016/J.Jalz.2014.05.024 |
0.356 |
|
| 2014 |
Rabinovici GD, Ossenkoppele R, Perrotin A, Dore V, Jagust W, Bouwman FH, La Joie R, Villemagne VL, Miller B, Van der Flier WM, de La Sayette V, Masters CL, Scheltens P, van Berckel B, Rowe CC, et al. IC-P-010: CLINICALLY DIAGNOSED PROBABLE AD CASES WITH A NEGATIVE AMYLOID PET SCAN: CLINICAL FINDINGS Alzheimer's & Dementia. 10: P12-P12. DOI: 10.1016/J.Jalz.2014.05.014 |
0.355 |
|
| 2014 |
Masters CL. HOW TO CHANGE AND MONITOR THE RATES OF AB AMYLOID ACCUMULATION AND COGNITIVE DECLINE IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P286-P286. DOI: 10.1016/J.Jalz.2014.04.474 |
0.458 |
|
| 2014 |
Bourgeat P, Doré V, Zhou L, Fripp J, Martins R, Macaulay L, Masters CL, Ames D, Brown B, Rowe CC, Salvado O, Villemagne VL. Automated Reporting Of Amyloid Pet Quantification On Brain Surface Through A Web Interface Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.424 |
0.455 |
|
| 2014 |
Chatterjee P, Lim WLF, Gupta VB, Sohrabi HR, Taddei K, Brown B, Masters CL, Morris JC, Martins R. Altered Plasma Phospholipid Composition In Autosomal Dominant Alzheimer'S Disease: A Dian Study Alzheimers & Dementia. 10: 260. DOI: 10.1016/J.Jalz.2014.04.412 |
0.525 |
|
| 2014 |
Villemagne VL, Burnham S, Brown B, Bourgeat P, Ellis KA, Yates P, Veljanovski R, Martins R, Macaulay L, Salvado O, Ames D, Masters CL, Rowe CC. PRECLINICAL EFFECTS OF Aβ DEPOSITION ON EPISODIC MEMORY AND DISEASE PROGRESSION Alzheimers & Dementia. 10: 229. DOI: 10.1016/J.Jalz.2014.04.326 |
0.503 |
|
| 2014 |
Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P. AMYLOID β-RELATED COGNITIVE DECLINE IN PRECLINICAL ALZHEIMER'S DISEASE IS MODERATED BY APOE AND BDNF POLYMORPHISMS Alzheimers & Dementia. 10: 221. DOI: 10.1016/J.Jalz.2014.04.305 |
0.455 |
|
| 2014 |
Burnham SC, Ames D, Baker D, Bush AI, Cobiac L, Doecke J, Ellis KA, Faux NG, Head R, Kiiveri H, Laws SM, Martins R, Maruff P, Savage G, Wilson B, ... ... Masters CL, et al. Predicting Alzheimer'S Disease From A Blood-Based Biomarker Profile: Results From Aipl At 54 Months Alzheimers & Dementia. 10: 196. DOI: 10.1016/J.Jalz.2014.04.233 |
0.484 |
|
| 2014 |
Rainey-Smith SR, Brown B, Gardener S, Peiffer J, Bourgeat P, Laws SM, Barnes M, Taddei K, Sohrabi HR, Weinborn M, Rembach A, Burnham S, Villemagne VL, Ellis KA, Macaulay L, ... Masters CL, et al. Apoe Genotype-Dependent Effects Of Diet And Physical Activity On Cognition And Alzheimer'S-Related Pathology: Data From The Aipl Study Of Ageing Alzheimers & Dementia. 10: 166. DOI: 10.1016/J.Jalz.2014.04.165 |
0.506 |
|
| 2014 |
Harrington K, Gould E, Lim YY, Ellis KA, Ames D, Martins R, Savage G, Szoeke C, Rowe CC, Villemagne VL, Masters CL, Maruff P. The Association Between Amyloid Burden And Sub-Clinical Depression In Healthy Older Adults Alzheimers & Dementia. 10: 139. DOI: 10.1016/J.Jalz.2014.04.086 |
0.43 |
|
| 2013 |
Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ, Bush AI, Szoeke C, Schembri A, Ames D, Masters CL. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease. Bmc Psychology. 1: 30. PMID 25566378 DOI: 10.1186/2050-7283-1-30 |
0.471 |
|
| 2013 |
Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R, Jones G, Maruff P, Woodward M, Price R, Robins P, Tochon-Danguy H, O'Keefe G, Pike KE, Yates P, ... ... Masters CL, et al. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Annals of Neurology. 74: 905-13. PMID 24448836 DOI: 10.1002/Ana.24040 |
0.564 |
|
| 2013 |
Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, Bush AI, Masters CL, Roberts BR. Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction. International Journal of Alzheimer's Disease. 2013: 623241. PMID 24228186 DOI: 10.1155/2013/623241 |
0.714 |
|
| 2013 |
Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Masters CL, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/Pnas.1317918110 |
0.51 |
|
| 2013 |
Hare DJ, Grubman A, Ryan TM, Lothian A, Liddell JR, Grimm R, Matsuda T, Doble PA, Cherny RA, Bush AI, White AR, Masters CL, Roberts BR. Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry. Metallomics : Integrated Biometal Science. 5: 1656-62. PMID 24132241 DOI: 10.1039/C3Mt00227F |
0.608 |
|
| 2013 |
Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN. Pupil response biomarkers for early detection and monitoring of Alzheimer's disease. Current Alzheimer Research. 10: 931-9. PMID 24117119 DOI: 10.2174/15672050113106660163 |
0.569 |
|
| 2013 |
Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, et al. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology. 81: 1425-33. PMID 24049139 DOI: 10.1212/Wnl.0B013E3182A841C6 |
0.37 |
|
| 2013 |
Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, Matěj R, Howley R, Farrell M, Breithaupt M, Zerr I, van Duijn C, Ibrahim-Verbaas C, Mackenzie J, Will RG, et al. Intensity of human prion disease surveillance predicts observed disease incidence. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1372-7. PMID 23965290 DOI: 10.1136/Jnnp-2012-304820 |
0.349 |
|
| 2013 |
Frost SM, Kanagasingam Y, Sohrabi HR, Taddei K, Bateman R, Morris J, Benzinger T, Goate A, Masters CL, Martins RN. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Current Alzheimer Research. 10: 790-6. PMID 23919771 DOI: 10.2174/15672050113109990154 |
0.53 |
|
| 2013 |
Rembach A, Ryan TM, Roberts BR, Doecke JD, Wilson WJ, Watt AD, Barnham KJ, Masters CL. Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. Biomarkers in Medicine. 7: 641-62. PMID 23905901 DOI: 10.2217/bmm.13.59 |
0.639 |
|
| 2013 |
Lothian A, Hare DJ, Grimm R, Ryan TM, Masters CL, Roberts BR. Metalloproteomics: principles, challenges and applications to neurodegeneration. Frontiers in Aging Neuroscience. 5: 35. PMID 23882215 DOI: 10.3389/fnagi.2013.00035 |
0.568 |
|
| 2013 |
Harrington KD, Lim YY, Ellis KA, Copolov C, Darby D, Weinborn M, Ames D, Martins RN, Savage G, Szoeke C, Rowe C, Villemagne VL, Masters CL, Maruff P. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. International Psychogeriatrics / Ipa. 25: 1667-77. PMID 23866942 DOI: 10.1017/S1041610213001087 |
0.554 |
|
| 2013 |
Simpson M, Johanssen V, Boyd A, Klug G, Masters CL, Li QX, Pamphlett R, McLean C, Lewis V, Collins SJ. Unusual clinical and molecular-pathological profile of gerstmann-Sträussler-Scheinker disease associated with a novel PRNP mutation (V176G). Jama Neurology. 70: 1180-5. PMID 23857164 DOI: 10.1001/Jamaneurol.2013.165 |
0.369 |
|
| 2013 |
Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, et al. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 34: 2457-64. PMID 23769397 DOI: 10.1016/J.Neurobiolaging.2013.05.006 |
0.651 |
|
| 2013 |
Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Brain : a Journal of Neurology. 136: 2201-16. PMID 23737466 DOI: 10.1093/Brain/Awt127 |
0.512 |
|
| 2013 |
Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Jama Neurology. 70: 903-11. PMID 23712469 DOI: 10.1001/Jamaneurol.2013.1062 |
0.522 |
|
| 2013 |
Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, Martins RN, Masters CL, O'Meara T, Savage G, Szoeke C, Villemagne VL, Ellis KA. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. International Psychogeriatrics / Ipa. 25: 1307-15. PMID 23693133 DOI: 10.1017/S1041610213000665 |
0.451 |
|
| 2013 |
Lim YY, Ellis KA, Harrington K, Kamer A, Pietrzak RH, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Ames D, Maruff P. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease. Neuropsychology. 27: 322-32. PMID 23688214 DOI: 10.1037/A0032321 |
0.64 |
|
| 2013 |
Ryan TM, Caine J, Mertens HD, Kirby N, Nigro J, Breheney K, Waddington LJ, Streltsov VA, Curtain C, Masters CL, Roberts BR. Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization. Peerj. 1: e73. PMID 23678397 DOI: 10.7717/peerj.73 |
0.606 |
|
| 2013 |
Nisbet RM, Nuttall SD, Robert R, Caine JM, Dolezal O, Hattarki M, Pearce LA, Davydova N, Masters CL, Varghese JN, Streltsov VA. Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide. Proteins. 81: 1748-58. PMID 23609990 DOI: 10.1002/Prot.24312 |
0.364 |
|
| 2013 |
Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters CL, Villemagne VL. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 880-6. PMID 23575995 DOI: 10.2967/Jnumed.112.114785 |
0.335 |
|
| 2013 |
Lim YY, Jaeger J, Harrington K, Ashwood T, Ellis KA, Stöffler A, Szoeke C, Lachovitzki R, Martins RN, Villemagne VL, Bush A, Masters CL, Rowe CC, Ames D, Darby D, et al. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 320-30. PMID 23552802 DOI: 10.1093/Arclin/Act021 |
0.623 |
|
| 2013 |
Kenche VB, Zawisza I, Masters CL, Bal W, Barnham KJ, Drew SC. Mixed ligand Cu2+ complexes of a model therapeutic with Alzheimer's amyloid-β peptide and monoamine neurotransmitters. Inorganic Chemistry. 52: 4303-18. PMID 23537393 DOI: 10.1021/Ic302289R |
0.384 |
|
| 2013 |
Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. The Lancet. Neurology. 12: 357-67. PMID 23477989 DOI: 10.1016/S1474-4422(13)70044-9 |
0.55 |
|
| 2013 |
Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Translational Psychiatry. 3: e233. PMID 23443359 DOI: 10.1038/Tp.2012.150 |
0.571 |
|
| 2013 |
Watt AD, Perez KA, Rembach A, Sherrat NA, Hung LW, Johanssen T, McLean CA, Kok WM, Hutton CA, Fodero-Tavoletti M, Masters CL, Villemagne VL, Barnham KJ. Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples. Acta Neuropathologica. 125: 549-64. PMID 23354835 DOI: 10.1007/S00401-013-1083-Z |
0.408 |
|
| 2013 |
Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Chételat G, Raniga P, Mulligan RS, Salvado O, Putz B, Roth K, Masters CL, Reininger CB, Rowe CC. (18)F-florbetaben Aβ imaging in mild cognitive impairment. Alzheimer's Research & Therapy. 5: 4. PMID 23324163 DOI: 10.1186/Alzrt158 |
0.333 |
|
| 2013 |
Ellis KA, Lim YY, Harrington K, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 34: 861-71. PMID 23302660 DOI: 10.3233/Jad-122170 |
0.575 |
|
| 2013 |
Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ. Research and standardization in Alzheimer's trials: reaching international consensus. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 160-8. PMID 23266004 DOI: 10.1016/J.Jalz.2012.10.006 |
0.548 |
|
| 2013 |
Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, ... ... Masters CL, et al. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 34: 171-82. PMID 23168449 DOI: 10.3233/Jad-121474 |
0.752 |
|
| 2013 |
Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease? Journal of Alzheimer's Disease : Jad. 33: 1167-76. PMID 23160011 DOI: 10.3233/Jad-121771 |
0.565 |
|
| 2013 |
Lim YY, Ellis KA, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Aβ amyloid, cognition, and APOE genotype in healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 538-45. PMID 23159043 DOI: 10.1016/J.Jalz.2012.07.004 |
0.504 |
|
| 2013 |
Lim YY, Pietrzak RH, Ellis KA, Jaeger J, Harrington K, Ashwood T, Szoeke C, Martins RN, Bush AI, Masters CL, Rowe CC, Villemagne VL, Ames D, Darby D, Maruff P. Rapid decline in episodic memory in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 33: 675-9. PMID 23001710 DOI: 10.3233/Jad-2012-121516 |
0.551 |
|
| 2013 |
Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, Taddei T, Ward VK, Rodrigues MA, Burnham S, Rainey-Smith SR, Villemagne VL, Bush A, Ellis KA, Masters CL, et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Molecular Psychiatry. 18: 875-81. PMID 22889922 DOI: 10.1038/Mp.2012.107 |
0.588 |
|
| 2013 |
Copolov C, Harrington K, Dow B, Joosten M, Rainey-Smith S, Rodrigues M, Rembach A, Macaulay L, Rowe C, Martins R, Masters C, Ames D, Ellis K. The effect of rapid cognitive decline in MCI and Alzheimer's disease on level of dependence, resource utilization, carer satisfaction, burden and attitudes to aging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.996 |
0.529 |
|
| 2013 |
Buckley R, Saling M, Irish M, Ames D, Rowe C, Lautenschlager N, Maruff P, Macaulay L, Martins R, Masters C, O'Meara T, Savage G, Szoeke C, Villemagne V, Ellis K. P2-267: Neuropsychological predictors of autobiographical memory impairment in mild cognitive impairment (MCI) Alzheimer's & Dementia. 9: P456-P456. DOI: 10.1016/J.Jalz.2013.05.914 |
0.427 |
|
| 2013 |
Johnson P, Graham P, Wilson B, Macaulay L, Maruff P, Savage G, Ellis K, Martins R, Rowe C, Masters C, Ames D, Zhang P. Genetic algorithm with logistic regression for Alzheimer's disease diagnosis and prognosis Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.913 |
0.487 |
|
| 2013 |
Restrepo C, Saling M, Ames D, Bush A, Faux N, Martins R, Maruff P, Masters C, Rowe C, Szoeke C, Villemagne V, Yates P, Ellis K. The effect of vascular risk factors on the rate of cognitive change in older adults: Data from the Australian Imaging Biomarkers and Lifestyle (AIBL) flagship study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.911 |
0.548 |
|
| 2013 |
Lim YY, Villemagne V, Laws S, Ames D, Pietrzak R, Ellis K, Harrington K, Bourgeat P, Salvado O, Darby D, Snyder P, Bush A, Martins R, Masters C, Rowe C, et al. Modulation of beta-amyloid-related cognitive decline by brain-derived neurotrophic factor Val66Met polymorphism in preclinical Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.893 |
0.654 |
|
| 2013 |
Lim YY, Ellis K, Harrington K, Kamer A, Pietrzak R, Bush A, Darby D, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Ames D, Maruff P. Cognitive consequences of high beta-amyloid levels in people with mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer's disease Alzheimers & Dementia. 9: 446. DOI: 10.1016/J.Jalz.2013.05.891 |
0.625 |
|
| 2013 |
Ryan T, Roberts B, McColl G, Metens H, Kirby N, Howlett G, Curtain C, Barnham K, Masters C. The antioligomer effects of the metal-protein attenuating compound clioquinol Alzheimers & Dementia. 9: 363. DOI: 10.1016/J.Jalz.2013.05.695 |
0.536 |
|
| 2013 |
Okamura N, Furumoto S, Harada R, Fodero-Tavoletti M, Mulligan RS, Masters C, Yanai K, Kudo Y, Rowe C, Villemagne V. In vivo detection of tau protein deposits in Alzheimer's disease using 18F-labeled 2-phenylquinoline derivatives Alzheimers & Dementia. 9: 268. DOI: 10.1016/J.Jalz.2013.05.533 |
0.408 |
|
| 2013 |
Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. Cortical surface projection of PET images from 11C- and 18F-labeled radiotracers without magnetic resonance imaging Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.523 |
0.374 |
|
| 2013 |
Fodero-Tavoletti M, Okamura N, Taylor L, Furumoto S, McLean C, Mulligan RS, Birchall I, Harada R, Masters C, Yanai K, Rowe C, Kudo Y, Villemagne V. THK523 selectively binds to neurofibrillary tangles and neuropils in people with Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.519 |
0.411 |
|
| 2013 |
Hung L, Watt A, Mulligan RS, Furumoto S, Fodero-Tavoletti M, Chan J, Yanai K, Masters C, Kudo Y, Rowe C, Barnham K, Villemagne V. P1-292: Detectable levels of white matter PHF-tau in Alzheimer's disease Alzheimer's & Dementia. 9: P261-P261. DOI: 10.1016/J.Jalz.2013.05.517 |
0.388 |
|
| 2013 |
Zhang P, Graham P, Savage G, Jones A, Macaulay L, Masters C, Martins R, Gupta VB, Bush A, Maruff P, Ellis K, Szoeke C, Rowe C, Ames D, Wilson B. Change in cognition over 36 months in relation to blood biomarkers Alzheimers & Dementia. 9: 204. DOI: 10.1016/J.Jalz.2013.05.372 |
0.55 |
|
| 2013 |
Rembach A, Wilson B, Ellis K, Ames D, Rowe C, Villemagne V, Bush A, Martins R, Masters C, Doecke J. Neutrophil-lymphocyte ratio in Alzheimer's disease: Data from the Australian Imaging Biomarker and Lifestyle study of ageing Alzheimers & Dementia. 9: 203. DOI: 10.1016/J.Jalz.2013.05.368 |
0.634 |
|
| 2013 |
Thomas J, Brier M, Bateman R, Snyder A, Benzinger T, Xiong C, Raichle M, Sperling R, Mayeux R, Ghetti B, Ringman J, Salloway S, McDade E, Rossor M, Schofield P, ... Masters C, et al. IC-P-184: Resting state functional connectivity in autosomal dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 9: P105-P105. DOI: 10.1016/J.Jalz.2013.05.181 |
0.491 |
|
| 2013 |
Zhang P, Macaulay L, Martins R, Maruff P, Savage G, Ellis K, Szoeke C, Masters C, Rowe C, Ames D, Riley M. P4-217: Association of BMI and change in BMI with cognitive function, change in cognitive function and conversion to Alzheimer's disease Alzheimer's & Dementia. 9: P785-P786. DOI: 10.1016/J.Jalz.2013.05.1609 |
0.481 |
|
| 2013 |
Darby D, Brodtmann A, Woodward M, Masters C. P4-188: The Trajectory-Related Early Alzheimer's Database (TREAD) study Alzheimer's & Dementia. 9: P774-P774. DOI: 10.1016/J.Jalz.2013.05.1579 |
0.391 |
|
| 2013 |
Villemagne V, Furumoto S, Fodero-Tavoletti M, Mulligan RS, Harada R, Yates P, Pejoska S, Yanai K, Masters C, Kudo Y, Rowe C, Okamura N. In vivo pattern of tau and beta-amyloid deposition in the brain might distinguish healthy individuals from those with preclinical Alzheimer's disease Alzheimers & Dementia. 9: 94. DOI: 10.1016/J.Jalz.2013.05.155 |
0.466 |
|
| 2013 |
Maruff P, Lim YY, Ames D, Ellis K, Pietrzak R, Savage G, Harrington K, Bush A, Szoeke C, Martins R, Villemagne V, Rowe C, Darby D, Masters C. Clinical utility of the cogstate brief battery in Alzheimer's disease–related memory impairment Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1296 |
0.587 |
|
| 2013 |
Cash D, Ridgway G, Modat M, Ryan N, Kinnunen K, Cardoso J, Benzinger T, Jack CR, Raichle M, Marcus D, Ringman J, Thompson P, Ghetti B, Salloway S, Sperling R, ... ... Masters C, et al. Dissociating volume and intensity differences in familial Alzheimer's disease Alzheimers & Dementia. 9: 603. DOI: 10.1016/J.Jalz.2013.05.075 |
0.515 |
|
| 2013 |
Doré V, Bourgeat P, Zhou L, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Brown B, Rowe C, Salvado O, Villemagne V. MR-less cortical surface-projection of PET images from 11C- and 18F-labeled radiotracers Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.017 |
0.373 |
|
| 2013 |
Rowe C, Ames D, Ellis K, Bourgeat P, Brown B, Salvado O, Szoeke C, Woodward M, Macaulay L, Maruff P, Martins R, Masters C, Villemagne V. Biomarker-based prediction of cognitive decline in 270 nondemented older individuals: Three-year follow-up results from the Australian Imaging Biomarkers and Lifestyle Study of Aging (AIBL) Alzheimers & Dementia. 9: 12. DOI: 10.1016/J.Jalz.2013.05.005 |
0.438 |
|
| 2013 |
Bourgeat P, Villemagne V, Dore V, Fripp J, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Rowe C, Salvado O. Automatic 11C PiB SUVR quantification Alzheimers & Dementia. 9: 597. DOI: 10.1016/J.Jalz.2013.05.004 |
0.368 |
|
| 2013 |
Rembach A, Wilson B, Villemagne V, Ellis K, Ames D, Rowe C, Bush A, Martins R, Masters C, Doecke J. Plasma beta-amyloid levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.341 |
0.67 |
|
| 2013 |
Yates P, Rowe C, Villemagne V, Desmond P, Masters C, Ames D, Dennerstein L, Philippe L, Ellis K, Szoeke C. Midlife vascular risk and late-life amyloid burden: Data from the Women's Healthy Ageing Project (WHAP) Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.300 |
0.314 |
|
| 2013 |
Villemagne V, Furumoto S, Fodero-Tavoletti M, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters C, Yanai K, Rowe C, Okamura N. In vivo pattern of tau and beta-amyloid deposition in the brain might distinguish healthy controls from preclinical Alzheimer's disease Alzheimers & Dementia. 9: 534. DOI: 10.1016/J.Jalz.2013.04.283 |
0.464 |
|
| 2013 |
Villemagne V, Burnham S, Bourgeat P, Brown B, Ellis K, Salvado O, Szoeke C, Macaulay L, Martins R, Maruff P, Ames D, Rowe C, Masters C. The natural history of the dynamics of beta-amyloid deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.253 |
0.576 |
|
| 2013 |
Yates P, Villemagne V, Desmond P, Phal P, Steward C, Salvado O, Martins R, Masters C, Ames D, Ellis K, Szoeke C, Rowe C. Microbleeds and clinical trajectories: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Alzheimers & Dementia. 9: 131. DOI: 10.1016/J.Jalz.2013.04.066 |
0.406 |
|
| 2013 |
Gupta VB, Rowe C, Szoeke C, Ames D, Cobiac L, Bush A, Ellis K, Macaulay L, Masters C, Martins R. Establishing apolipoprotein J as a potential candidate for Alzheimer's disease biomarker panel: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of aging Alzheimers & Dementia. 9: 128. DOI: 10.1016/J.Jalz.2013.04.057 |
0.643 |
|
| 2013 |
Kinnunen K, Ryan N, Cash D, Leite AB, Finnegan S, Cardoso M, Leung K, Modat M, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Ringman J, Ghetti B, ... ... Masters C, et al. Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent? Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.017 |
0.498 |
|
| 2013 |
Ryan TM, Roberts BR, Streltsov VA, Nuttall SD, Masters CL. The Role of Aβ in Alzheimer's Disease Amyloid Fibrils and Prefibrillar Aggregates: Molecular and Biological Properties. 263-293. DOI: 10.1002/9783527654185.ch13 |
0.678 |
|
| 2012 |
McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, Ryan TM, Masters CL, Barnham KJ, Bush AI, Cherny RA. Utility of an improved model of amyloid-beta (Aβâ‚â‚‹â‚„â‚‚) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Molecular Neurodegeneration. 7: 57. PMID 23171715 DOI: 10.1186/1750-1326-7-57 |
0.711 |
|
| 2012 |
Brown BM, Peiffer JJ, Sohrabi HR, Mondal A, Gupta VB, Rainey-Smith SR, Taddei K, Burnham S, Ellis KA, Szoeke C, Masters CL, Ames D, Rowe CC, Martins RN. Intense physical activity is associated with cognitive performance in the elderly. Translational Psychiatry. 2: e191. PMID 23168991 DOI: 10.1038/Tp.2012.118 |
0.408 |
|
| 2012 |
Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation. 2: 975-984. PMID 23139856 DOI: 10.4155/Cli.12.93 |
0.543 |
|
| 2012 |
Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology. 79: 1645-52. PMID 23071163 DOI: 10.1212/Wnl.0B013E31826E9Ae6 |
0.452 |
|
| 2012 |
Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL. Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. Bmc Psychiatry. 12: 167. PMID 23050829 DOI: 10.1186/1471-244X-12-167 |
0.475 |
|
| 2012 |
Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, Taddei K, Mondal A, Ward VK, Scarmeas N, Barnes M, Ellis KA, Head R, Masters CL, Ames D, et al. Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Translational Psychiatry. 2: e164. PMID 23032941 DOI: 10.1038/Tp.2012.91 |
0.536 |
|
| 2012 |
Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, ... ... Masters CL, et al. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 445-52. PMID 22959699 DOI: 10.1016/J.Jalz.2012.08.001 |
0.371 |
|
| 2012 |
Klemm HM, Welton JM, Masters CL, Klug GM, Boyd A, Hill AF, Collins SJ, Lawson VA. The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. The Journal of Biological Chemistry. 287: 36465-72. PMID 22930754 DOI: 10.1074/Jbc.M112.368803 |
0.347 |
|
| 2012 |
Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, ... ... Masters CL, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Archives of Neurology. 69: 1318-25. PMID 22801742 DOI: 10.1001/Archneurol.2012.1282 |
0.663 |
|
| 2012 |
Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, ... ... Masters CL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/Nejmoa1202753 |
0.551 |
|
| 2012 |
Anand A, Banik A, Thakur K, Masters CL. The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation. Current Alzheimer Research. 9: 1010-29. PMID 22698073 DOI: 10.2174/156720512803569055 |
0.379 |
|
| 2012 |
Masters CL, Selkoe DJ. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine. 2: a006262. PMID 22675658 DOI: 10.1101/Cshperspect.A006262 |
0.507 |
|
| 2012 |
Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain : a Journal of Neurology. 135: 2126-39. PMID 22628162 DOI: 10.1093/Brain/Aws125 |
0.513 |
|
| 2012 |
Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. Journal of Neurochemistry. 122: 208-20. PMID 22519988 DOI: 10.1111/J.1471-4159.2012.07761.X |
0.331 |
|
| 2012 |
Fodero-Tavoletti MT, Brockschnieder D, Villemagne VL, Martin L, Connor AR, Thiele A, Berndt M, McLean CA, Krause S, Rowe CC, Masters CL, Dinkelborg L, Dyrks T, Cappai R. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer. Nuclear Medicine and Biology. 39: 1042-8. PMID 22503458 DOI: 10.1016/J.Nucmedbio.2012.03.001 |
0.389 |
|
| 2012 |
Hung LW, Villemagne VL, Cheng L, Sherratt NA, Ayton S, White AR, Crouch PJ, Lim S, Leong SL, Wilkins S, George J, Roberts BR, Pham CL, Liu X, Chiu FC, ... ... Masters CL, et al. The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. The Journal of Experimental Medicine. 209: 837-54. PMID 22473957 DOI: 10.1084/Jem.20112285 |
0.667 |
|
| 2012 |
Ryan TM, Friedhuber A, Lind M, Howlett GJ, Masters C, Roberts BR. Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of Alzheimer disease peptide Aβ(1-42). The Journal of Biological Chemistry. 287: 16947-54. PMID 22461629 DOI: 10.1074/Jbc.M111.321778 |
0.675 |
|
| 2012 |
Watt AD, Perez KA, Rembach AR, Masters CL, Villemagne VL, Barnham KJ. Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing. Journal of Alzheimer's Disease : Jad. 30: 323-36. PMID 22426018 DOI: 10.3233/Jad-2012-120058 |
0.376 |
|
| 2012 |
Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury. Brain Research. 1451: 87-99. PMID 22424792 DOI: 10.1016/J.Brainres.2012.02.045 |
0.327 |
|
| 2012 |
Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O'Keefe G, Chan JG, Young K, Tochon-Danguy H, Masters CL, Rowe CC. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 983-9. PMID 22398958 DOI: 10.1007/S00259-012-2088-X |
0.401 |
|
| 2012 |
Barber B, Ames D, Ellis K, Martins R, Masters C, Szoeke C. Lifestyle and late life cognitive health: sufficient evidence to act now? International Psychogeriatrics / Ipa. 24: 683-8. PMID 22313892 DOI: 10.1017/S1041610211002912 |
0.398 |
|
| 2012 |
Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology. 78: 477-84. PMID 22302548 DOI: 10.1212/Wnl.0B013E318246D67A |
0.508 |
|
| 2012 |
Chételat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL, Rowe CC. Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease. Neuro-Degenerative Diseases. 10: 141-4. PMID 22301812 DOI: 10.1159/000334295 |
0.389 |
|
| 2012 |
Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, O'Keefe G, Jones G, Kung HF, Pontecorvo M, Masters CL, Skovronsky DM, Rowe CC. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging. Neuro-Degenerative Diseases. 10: 161-5. PMID 22261520 DOI: 10.1159/000334535 |
0.395 |
|
| 2012 |
Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P, The Aibl Research Group. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Clinical and Experimental Neuropsychology. 34: 345-58. PMID 22248010 DOI: 10.1080/13803395.2011.643227 |
0.511 |
|
| 2012 |
Acosta O, Fripp J, Doré V, Bourgeat P, Favreau JM, Chételat G, Rueda A, Villemagne VL, Szoeke C, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Bonner E, et al. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease. Journal of Neuroscience Methods. 205: 96-109. PMID 22226742 DOI: 10.1016/J.Jneumeth.2011.12.011 |
0.526 |
|
| 2012 |
Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0 |
0.399 |
|
| 2012 |
Johanssen VA, Barnham KJ, Masters CL, Hill AF, Collins SJ. Generating recombinant C-terminal prion protein fragments of exact native sequence. Neurochemistry International. 60: 318-26. PMID 22197912 DOI: 10.1016/J.Neuint.2011.12.006 |
0.32 |
|
| 2012 |
Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA. The role of metallobiology and amyloid-β peptides in Alzheimer's disease. Journal of Neurochemistry. 120: 149-66. PMID 22121980 DOI: 10.1111/J.1471-4159.2011.07500.X |
0.745 |
|
| 2012 |
James SA, Volitakis I, Adlard PA, Duce JA, Masters CL, Cherny RA, Bush AI. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radical Biology & Medicine. 52: 298-302. PMID 22080049 DOI: 10.1016/J.Freeradbiomed.2011.10.446 |
0.497 |
|
| 2012 |
Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing. International Psychogeriatrics / Ipa. 24: 197-204. PMID 21749739 DOI: 10.1017/S1041610211001335 |
0.632 |
|
| 2012 |
Masters CL. Neurodegenerative diseases of the elderly. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 2: 283-4. PMID 18638828 DOI: 10.1016/0967-5868(95)90045-4 |
0.367 |
|
| 2012 |
Villemagne VL, Furumoto S, Fodero-Tavoletti M, Harada R, Mulligan RS, Kudo Y, Masters CL, Yanai K, Rowe CC, Okamura N. The challenges of tau imaging Future Neurology. 7: 409-421. DOI: 10.2217/Fnl.12.34 |
0.39 |
|
| 2012 |
Doré V, Bourgeat P, Fripp J, Acosta O, Chetelat G, Szoeke C, Ellis KA, Martins RN, Villemagne V, Masters CL, Ames D, Rowe CC, Salvado O. A surface based approach for cortical thickness comparison between PiB+ and PiB-healthy control subjects Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8314. DOI: 10.1117/12.911752 |
0.546 |
|
| 2012 |
Masters C, Robert B, Ryan T, Lind M, Li Q-, Watt A, Cherny R, Barnham K. 49 Aβ oligomers as diagnostic and therapeutic targets for Alzheimer's disease Neurobiology of Aging. 33. DOI: 10.1016/J.Neurobiolaging.2012.01.067 |
0.466 |
|
| 2012 |
Villemagne V, Ellis K, Bourgeat P, Brown B, Jones G, Fripp J, Martins R, Salvado O, Ames D, Masters C, Rowe C. Sigmoidal kinetics of BETA-AMYLOID deposition: Twenty-year interval between normality and fully developed Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2013.08.148 |
0.576 |
|
| 2012 |
Appannah A, Szoeke C, Ellis K, Rowe C, Martins R, Masters C, Ames D, Bush A. Investigating cardiovascular risk factors on cognition: A two-cohort study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.878 |
0.527 |
|
| 2012 |
Faux N, Burnham S, Wilson B, Jones G, Laws S, Bedo J, Ames D, Bush A, Doecke J, Ellis K, Head R, Kiiveri H, Macaulay L, Martins R, Masters C, et al. An update on an AIBL blood-based biomarker panel for the prediction of Aβ burden Alzheimers & Dementia. 8: 283. DOI: 10.1016/J.Jalz.2012.05.764 |
0.58 |
|
| 2012 |
Watt A, Perez K, Sherratt N, Rembach A, Hung L, McLean C, Fodero-Tavoletti M, Masters C, Villemagne V, Barnham K. Profiling beta-amyloid in the Alzheimer's disease brain Alzheimers & Dementia. 8: 270. DOI: 10.1016/J.Jalz.2012.05.724 |
0.454 |
|
| 2012 |
Watt A, Perez K, Rembach A, Masters C, Villemagne V, Barnham K. Variability in blood-based beta-amyloid assays: The need for consensus on preanalytical processing Alzheimers & Dementia. 8: 270. DOI: 10.1016/J.Jalz.2012.05.723 |
0.357 |
|
| 2012 |
Becker J, Koeppe R, Benzinger T, Jack C, Marcus D, Raichle M, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, Brickman A, Ghetti B, Masters C, et al. FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.655 |
0.523 |
|
| 2012 |
Chhatwal J, Schultz A, Johnson K, Benzinger T, Jack C, Salloway S, Ringman J, Koeppe R, Marcus D, Thompson P, Saykin A, Correia S, Schofield P, Rowe C, Fox N, ... ... Masters C, et al. O2-06-01: Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study Alzheimer's & Dementia. 8: P244-P245. DOI: 10.1016/J.Jalz.2012.05.654 |
0.513 |
|
| 2012 |
Burnham S, Graham P, Wilson B, Ames D, Macaulay L, Martins R, Masters C, Maruff P, Rowe C, Szoeke C, Ryan L, Ellis K. Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort Alzheimers & Dementia. 8: 131. DOI: 10.1016/J.Jalz.2012.05.347 |
0.502 |
|
| 2012 |
Burnham S, Wilson B, Graham P, Kiiveri H, Ames D, Macaulay L, Martins R, Masters C, Rowe C, Salvado O, Szoeke C, Villemagne V, Ellis K. Cognitive assessments as estimators of neocortical beta-amyloid burden in the AIBL cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.346 |
0.487 |
|
| 2012 |
Villemagne V, Ellis K, Chetelat G, Brown B, Bourgeat P, Jones G, Martins R, Salvado O, Ames D, Masters C, Rowe C. Relation between rates of Aβ deposition, APOE genotype and cognition: Results from a 3- to 5-year longitudinal study Alzheimers & Dementia. 8: 113. DOI: 10.1016/J.Jalz.2012.05.293 |
0.498 |
|
| 2012 |
Gupta VB, Wilson A, Rainey-Smith S, Laws S, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Establishing apolipoprotein E as a biomarker for Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) Flagship Study of Ageing Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.285 |
0.637 |
|
| 2012 |
Rowe C, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters C, Villemagne V. Head-to-head comparison of 11C-PiB and 18F-AZD4694 for beta-amyloid imaging in aging and dementia Alzheimers & Dementia. 8: 91. DOI: 10.1016/J.Jalz.2012.05.223 |
0.345 |
|
| 2012 |
Rainey-Smith S, Brown B, Ruyck KD, Laws S, Wilson A, Gupta VB, Ames D, Ellis K, Taddei K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Martins R. Alzheimer's disease-related changes in plasma brain-derived neurotrophic factor levels: Data from the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.2035 |
0.512 |
|
| 2012 |
Laws S, Bender S, Rainey-Smith S, Wilson A, Gupta VB, Ruyck Kd, Bush A, Ellis K, Macaulay L, Rowe C, Szoeke C, Taddei K, Ames D, Masters C, Martins R. Alzheimer's disease–related changes in plasma cortisol levels and gene involvement in the AIBL study Alzheimers & Dementia. 8: 407. DOI: 10.1016/J.Jalz.2012.05.2034 |
0.611 |
|
| 2012 |
Benzinger T, Blazey T, Ances B, Raichle M, Ances B, Snyder A, Su Y, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Masters C, et al. IC-P-128: Progressive white matter abnormalities in autosomal dominant Alzheimer's disease: Results of the DIAN study Alzheimer's & Dementia. 8: P68-P69. DOI: 10.1016/j.jalz.2012.05.1858 |
0.499 |
|
| 2012 |
Laws S, Lam C, Mondal A, Bush A, Ellis K, Macaulay L, Rowe C, Taddei K, Szoeke C, Ames D, Masters C, Martins R. Gene combination associations with Alzheimer's disease risk and quantitative traits in the AIBL study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1838 |
0.606 |
|
| 2012 |
Kinnunen K, Cash D, Leung K, Liang Y, Cardoso M, Modat M, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, ... ... Masters C, et al. Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.172 |
0.506 |
|
| 2012 |
Restrepo C, Saling M, Yates P, Villemagne V, Ames D, Bush A, Faux N, Martins R, Masters C, Rowe C, Szoeke C, Ellis K. The effect of vascular risk factors on cognition in older adults: Data from the AIBL study Alzheimers & Dementia. 8: 635. DOI: 10.1016/J.Jalz.2012.05.1693 |
0.521 |
|
| 2012 |
Yates P, Desmond P, Raniga P, Phal P, Steward C, Salvado O, Martins R, Salinas S, Ellis K, Szoeke C, Masters C, Ames D, Villemagne V, Rowe C. Incidence and Associations of Lobar Microbleeds: Results From the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (Aibl) Alzheimers & Dementia. 8: 33-33. DOI: 10.1016/J.Jalz.2012.05.1642 |
0.416 |
|
| 2012 |
Lim YY, Harrington K, Ellis K, Ames D, Ashwood T, Jaeger J, Lachovitzki R, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Darby D, Maruff P. The Australian Imaging, Biomarkers and Lifestyle-Rate of Change sub-study (AIBL-ROCS): Rationale, design, acceptability and pilot data for the first three months of assessment Alzheimers & Dementia. 8: 557. DOI: 10.1016/J.Jalz.2012.05.1500 |
0.386 |
|
| 2012 |
Ellis K, Lim YY, Ames D, Darby D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Maruff P. Aβ amyloid, cognition and APOE genotype in the preclinical stages of Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1499 |
0.594 |
|
| 2012 |
Kamer A, Ellis K, Kinsella G, Ames D, Martins R, Rowe C, Macaulay L, Szoeke C, Masters C. APOE and cognitive dysfunction in Alzheimer's dementia and mild cognitive impairment Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1441 |
0.489 |
|
| 2012 |
Raffelt D, Tournier JD, Crozier S, Ellis K, Martins R, Villemagne V, Masters C, Ames D, Rowe C, Salvado O, Connelly A. Apparent fibre density: A novel MRI approach that identifies specific white matter tracts affected in Alzheimer's disease and MCI Alzheimers & Dementia. 8: 61-61. DOI: 10.1016/J.Jalz.2012.05.142 |
0.514 |
|
| 2012 |
Cyarto E, Cox K, Desmond P, Ames D, Szoeke C, Salvado O, Sharman M, Ellis K, Phal P, Masters C, Rowe C, Martins R, Lautenschlager N. AIBL ACTIVE: A randomized controlled trial of physical activity to delay the progression of white matter hyperintensities on MRI in older adults at risk of cognitive decline Alzheimers & Dementia. 8: 506. DOI: 10.1016/J.Jalz.2012.05.1377 |
0.479 |
|
| 2012 |
Gardener S, Rainey-Smith S, Gu Y, Taddei K, Laws S, Gupta VB, Ames D, Ellis K, Head R, Macaulay L, Masters C, Rowe C, Szoeke C, Clifton P, Keogh J, et al. Diet, neuroimaging biomarkers and Alzheimer's disease: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing Alzheimers & Dementia. 8: 503. DOI: 10.1016/J.Jalz.2012.05.1365 |
0.521 |
|
| 2012 |
Brown B, Peiffer J, Gupta VB, Taddei K, Salvado O, Villemagne V, Rainey-Smith S, Ellis K, Ames D, Rowe C, Masters C, Szoeke C, Martins R. Level of physical activity is associated with hippocampal volume in a subgroup of the AIBL cohort Alzheimers & Dementia. 8: 494. DOI: 10.1016/J.Jalz.2012.05.1341 |
0.39 |
|
| 2012 |
Szoeke C, Ellis K, Zhang P, Rowe C, Martins R, Masters C, Ames D. A return to clinical skills in the early diagnosis of Alzheimer's disease Alzheimers & Dementia. 8: 491. DOI: 10.1016/J.Jalz.2012.05.1331 |
0.523 |
|
| 2012 |
Benzinger T, Blazey T, Koeppe R, Jack C, Raichle M, Su Y, Snyder A, Marcus D, Ringman J, Thompson P, Ghetti B, Saykin A, Salloway S, Correia S, Johnson K, ... ... Masters C, et al. Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.132 |
0.563 |
|
| 2012 |
Ellis K, Maruff P, Martins R, Masters C, McBride S, Macaulay L, Rowe C, Rainey-Smith S, Rembach A, Savage G, Szoeke C, Taddei K, Villemagne V, Zhang P, Ames D. Rates of conversion to MCI and Alzheimer's in the Australian Imaging, Biomarkers and Lifestyle (AIBL) cohort over 36 months Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1312 |
0.504 |
|
| 2012 |
Lim YY, Ellis K, Ames D, Harrington K, Martins R, Masters C, Rowe C, Savage G, Szoeke C, Villemagne V, Pietrzak R, Maruff P. Effect of Aβ burden and apolipoprotein E-ε4 on cognitive decline at 18 months in healthy older adults Alzheimers & Dementia. 8: 439. DOI: 10.1016/J.Jalz.2012.05.1168 |
0.461 |
|
| 2012 |
Rowe C, Ellis K, Brown B, Bourgeat P, Faux N, Martins R, Salvado O, Masters C, Ames D, Villemagne V. Cognition, hippocampal volume and fibrillar Aβ burden as predictors of cognitive decline: Three-year follow-up results from AIBL Alzheimers & Dementia. 8: 433. DOI: 10.1016/J.Jalz.2012.05.1154 |
0.464 |
|
| 2012 |
Dore V, Fripp J, Bourgeat P, Acosta O, Zhou L, Raniga P, Martins R, Macaulay L, Ellis K, Masters C, Ames D, Villemagne V, Rowe C, Salvado O. Longitudinal analysis of cortical thickness in PiB+ and PiB- healthy elderly controls Alzheimers & Dementia. 8: 34. DOI: 10.1016/J.Jalz.2012.05.088 |
0.399 |
|
| 2012 |
Bourgeat P, Fripp J, Raniga P, Dore V, Zhou L, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Villemagne V, Rowe C, Salvado O. Longitudinal modeling of joint PiB/MRI changes in Alzheimer's disease Alzheimers & Dementia. 8: 29. DOI: 10.1016/J.Jalz.2012.05.075 |
0.519 |
|
| 2012 |
Bourgeat P, Salvado O, Raniga P, Dore V, Zhou L, Martins R, Macaulay L, Masters C, Ames D, Ellis K, Villemagne V, Rowe C, Fripp J. Classification of Alzheimer's subject based on PiB-MR manifold learning Alzheimers & Dementia. 8: 344. DOI: 10.1016/J.Jalz.2012.05.074 |
0.46 |
|
| 2012 |
Kinnunen K, Cash D, Liang Y, Leung K, Cardoso M, Modat M, Malone I, Yeatman T, Nicholas J, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, ... ... Masters C, et al. Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study Alzheimers & Dementia. 8: 23. DOI: 10.1016/J.Jalz.2012.05.064 |
0.506 |
|
| 2012 |
Ong K, Villemagne V, Bahar-Fuchs A, Lamb F, Reininger C, Putz B, Rohde B, Masters C, Rowe C. Cognitive change and Aβ deposition in MCI subjects studied with serial 18F-florbetaben PET over 2 years Alzheimers & Dementia. 8: 258. DOI: 10.1016/J.Jalz.2012.05.063 |
0.343 |
|
| 2012 |
Cash D, Ridgway G, Ryan N, Kinnunen K, Yeatman T, Malone I, Benzinger T, Koeppe R, Jack C, Raichle M, Marcus D, Ringman J, Thompson P, Saykin A, Salloway S, ... ... Masters C, et al. A voxel-based morphometry study of volumetric MRI in familial Alzheimer’s disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.052 |
0.464 |
|
| 2012 |
Bateman R, Benzinger T, Cairns N, Fagan A, Goate A, Marcus D, Storandt M, Xiong C, Buckles V, Holtzman D, Moulder K, Oliver A, Santacruz A, Fox N, Ghetti B, ... ... Masters C, et al. Presymptomatic Alzheimer's disease in the Dominantly Inherited Alzheimer's Network (DIAN) Alzheimers & Dementia. 8: 4. DOI: 10.1016/J.Jalz.2012.05.015 |
0.549 |
|
| 2011 |
Lawson VA, Klemm HM, Welton JM, Masters CL, Crouch P, Cappai R, Ciccotosto GD. Gene knockout of tau expression does not contribute to the pathogenesis of prion disease. Journal of Neuropathology and Experimental Neurology. 70: 1036-45. PMID 22002429 DOI: 10.1097/Nen.0B013E318235B471 |
0.399 |
|
| 2011 |
Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, ... ... Masters CL, et al. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. Journal of Alzheimer's Disease : Jad. 27: 909-22. PMID 21891867 DOI: 10.3233/Jad-2011-110752 |
0.601 |
|
| 2011 |
Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, Parker SJ, Greenough MA, Volitakis I, Adlard PA, Cherny RA, Masters CL, Bush AI, Barnham KJ, White AR. The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity. Journal of Neurochemistry. 119: 220-30. PMID 21797865 DOI: 10.1111/J.1471-4159.2011.07402.X |
0.541 |
|
| Hide low-probability matches. |
